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Abstract 
Why Make Fat?: The Impact of de novo Fatty Acid Synthesis on Fat Storage, Reproduction, 
and Longevity in C. e/egans 
Carissa Perez Olsen 
Chair of the Supervisory Committee: 
Professor Marc Van Gilst 
Assistant Member, Basic Science Division, FHCRC 
Metabolic flux analysis allows for the understanding of how multiple pathways are integrated 
onto the core metabolism of an animal as it encounters different environmental and 
physiological challenges. Here, we have developed and implemented a stable 13C isotope 
approach in C. e/egans that allows us to monitor how the animals are utilizing their diet. This 
"mixed isotope" strategy can specifically quantify various aspects of fatty acid metabolism and 
can accurately determine whether the fats of the animals are absorbed directly from the diet or 
synthesized de novo. We have used this mixed labeling strategy to define how known fat 
storage genes, such as the insulin receptor, impact lipid metabolism pathways. In doing so, we 
have been able to establish that elevated de novo fatty acid synthesis is the main driver of fat 
accumulation in daf-2 animals. Additionally, this type of analysis allowed us to determine that 
the longevity and fat storage phenotypes of the daf-2 animals are separable. 
In addition, we have used this strategy to identify several novel regulators of de novo fatty 
acid synthesis. These regulators include oxidative phosphorylation and peroxisomal ~­
oxidation, which have not been previously implicated in the regulation of lipogenesis. In 
addition, we found that reproduction is also a key driver of de novo fatty acid synthesis as adult 
animals have significantly more synthesized fatty acids than their larval counterparts. Because 
reproduction requires a large amount of resources, we hypothesize that a lipogenic shift is an 
important component for successful progeny production and continued somatic maintenance. 
Finally, we have also found that RNAi of the fatty acid synthase gene results in a reduction in 
the adult lifespan indicating an important function for lipogenesis in the adult. 
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CHAPTER I: Lipid Metabolism Pathways and Fatty Acid Allocation 
An animal must utilize its dietary resources to produce energy and to generate 
biomolecules for maintenance, growth, and repair. In addition, resources must be allocated 
for long-term storage and reproduction. An imbalance in how an animal juggles these 
requirements may have a significant impact on its health, fecundity and longevity. In this 
work, we use the model system, Caenorhabditis e/egans, to understand how genes and 
pathways contribute to the regulation of dietary nutrient allocation, in particular the 
regulation of de novo fatty acid synthesis. To do this, it was necessary to develop a strategy 
to track how an animal processes and partitions its dietary nutrients. Elegant stable 13C 
isotope labeling strategies have been developed in other systems that monitor flux through 
metabolic pathways, and we have developed such an approach to define the relative 
contribution of dietary fat absorption and de novo fatty acid synthesis to the fatty acid pool in 
C. e/egans. The development of the mixed isotope strategy has allowed us to interrogate 
how various genes and pathways influence nutrient utilization and to investigate how 
imbalances in the partitioning of dietary resources can impact fat storage, aging and 
reproduction. Here, we discuss the lipid metabolism pathways that impact dietary allocation 
of nutrients as well as the consequences of their perturbation. 
Inappropriate Nutrient Allocation Impacts Fat Storage 
Fatty acids from the diet are used for a number of important processes including the 
generation of large quantities of energy when they are broken down by mitochondrial ~­
oxidation. In addition to providing an organism with sufficient levels of ATP, fatty acids are 
also essential components of cellular membranes (phospholipids), long-term energy storage 
reserves (triglycerides) and even function in signaling pathways (glycolipids) (Figure 1.1). 
The amount of fatty acid allocated to each fate must be carefully regulated, as too much or 
too little fat in any branch can be problematic. Perhaps, the most familiar example of an 
imbalance in these pathways is in the total amount of fat storage in an animal. It has been 
well recognized that the increased allocation of fatty acids to triglycerides contributes to 
accumulation of excess fat stores and the resultant disorders such as metabolic disease and 
obesity. However, it is often forgotten that too little fat can also have serious consequences, 
as energy reserves are required for surviving even short periods of fasting. Genetic 
mutations that result in the reduced capacity to store fat can result in severe diseases 
including lipodystrophy (Halaschek-Wiener et aI., 2005). Additionally, mutations in 
mitochondrial ~-oxidation enzymes that reduce an individual's ability to access fat stores can 
result in severe hypoglycemia and even sudden death if not managed properly (Kompare et 
al.,2008). 
Here, we will consider the impact of excess fat stores as obesity and metabolic disorders 
have become increasingly prevalent in the last century with over 30% of the United States 
population being considered obese in 2008 (Flegal et aI., 2010). Excess body weight has a 
negative impact on an individual's overall health and is associated with an increased 
incidence of many prevalent diseases including type /I diabetes, cardiovascular disease, 
hypertension, and many cancers (Wang et aI., 2011; Watts, 2009). In fact, obesity 
increases the overall likelihood of death by 20% (Shi et aI., 2004). Total fat storage can be 
influenced by both dietary fat absorption and the de novo synthesis of fatty acids, and, 
because increased flux through either of these pathways can have dramatic impacts on fat 
storage, both fat metabolism pathways have been explored as potential pharmacological 
targets to combat obesity and metabolic disorders. 
Although environmental factors playa substantial role in determining body weight, there 
is a large genetic component that has been estimated at 40% to 70% (McPherson, 2007). 
In fact, the genetic basis for obesity is equal to or greater than the genetic basis of height 
(Ashrafi, 2007). The genetics of fat storage are highly polygenic with mutations in single 
genes accounting for a very small proportion of obesity cases, making it difficult to define the 
genetic determinants of fat storage. Additionally, studies in mammals and other model 
systems have identified hundreds of genes that impact fat accumulation; however, the sheer 
number of genes makes it difficult to determine how each individual gene impacts fat 
storage (Ashrafi et aI., 2003; McPherson, 2007). In theory, genes that impact total fat 
storage can do so by affecting three major processes: (1) synthesis of new fats, (2) food 
intake and absorption, and (3) breakdown of fats by ~-oxidation (McPherson, 2007). These 
metabolic pathways are coordinated to allow the proper balances of glucose and fat 
synthesis and breakdown (Figure 1.2). 
De Novo Fatty Acid Synthesis 
Fatty acids can be synthesized de novo from carbohydrate precursors via the function of 
two enzymes, acetyl-CoA carboxylase (ACC) and fatty acid synthase (FASN-1). The first 
and rate-limiting step of fatty acid biosynthesis is the generation of a malonyl-CoA primer by 
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the ATP-dependent carboxylation of acetyl-CoA by the ACC enzyme. The FASN enzyme is 
a homodimeric multidomain enzyme that then catalyzes the condensation of acetyl-CoA 
molecules to generate the 16-carbon fatty acid, palmitate (C16:0) (Figure 1.3A). The 
resulting palmitate can then be modified into a diverse set of fatty acids by a series of fatty 
acid elongation and desaturation enzymes (Figure 1.3B). 
Expression of the fatty acid synthase enzyme can be found in almost every adult tissue; 
however, its function is limited in most contexts. There is high expression of the fatty acid 
synthase protein in hormone-sensitive tissues and in metabolically active tissues including 
the liver and adipose, where FASN is responsible for converting excess dietary 
carbohydrates to fats (Menendez et aI., 2007; Shi et aI., 2004). FASN also generates the 
fatty acids for a number of specialized functions like supplying fatty acid components of milk 
during lactation and synthesizing fatty acids for surfactant production in the lungs (Kusakabe 
et aI., 2000). Although fatty acid synthesis is limited in most adult tissues, de novo fatty acid 
synthesis does play an essential role in development. FASN is broadly expressed in the 
mouse embryo with the highest levels of expression coinciding with areas of tissue-tissue 
interaction, tissue outgrowth and progressive modeling/remodeling (Chirala et aI., 2003). 
Additionally, fatty acid synthesis is essential during embryonic development as homozygous 
mutation of the fasn locus results in embryonic lethality. The heterozygous FAS mutants 
(Fasn +1-) were recovered at lower than expected frequency (-70% fewer animals) indicating 
partial haploid insufficiency as well (Chirala et aI., 2003). In these mice models, it was 
further demonstrated that dietary supplementation of saturated fatty acids did not fully 
rescue these phenotypes, presumably because transport of fatty acids through the placenta 
is limited. Not only do these studies indicate the importance of fatty acid synthesis in 
embryonic development, but they also highlight the need to consider teratogenic 
consequences of reducing fatty acid synthase activity. 
The expression of fatty acid synthase is tightly linked to the diet of an animal with FASN 
expression being induced by the presence of carbohydrates and suppressed by fat. The 
modulation of FASN expression is largely regulated transcriptionally by the activity of the 
sterol response element binding protein (SREBP); however, post-translational mechanisms 
of regulation also impact FASN abundance including protease degradation (Menendez et 
aI., 2007). A number of signaling and hormone pathways have been found to affect the 
overall levels of fatty acid synthesis through the modulation of the enzyme itself or through 
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the SREBP transcription factor including both the Pl3-Kinase and epidermal growth factor 
(EGF) pathways. 
Food Intake and Dietary Absorption 
The majority of fatty acids can be obtained directly from the diet, and because fat 
absorption requires less energy than de novo fatty acid synthesis, fatty acids inhibit FASN 
activity. Although nematodes do not contain leptin or any other neuropeptides known to 
regulate mammalian food intake, many of the enzymes required for the absorption of dietary 
fat are intact (Mullaney et aI., 2009). The absorption of dietary triglycerides (TAGs) and 
phospholipids (PL) requires partial breakdown of the molecule. In animals, TAGs are 
broken down by gastric and pancreatic lipases which enzymatically cleave the fatty acid tails 
from the head group to allow for efficient absorption. Phospholipases function similarly on 
PL to generate free fatty acids which can then be absorbed. Fatty acid transport proteins 
and fatty acid binding proteins then facilitate the transport of fatty acids throughout the 
animal. 
Fatty Acid Utilization by Mitochondrial ~-Oxidation 
Fatty acids can be broken down in the mitochondria and/or the peroxisome by ~­
oxidation pathways, although mitochondrial oxidation is the only energy production pathway. 
The resulting acetyl-GoA molecules are fed into the TGA cycle for the production of NADH 
and FADH2. When the amount of fatty acid funneled into ~-oxidation is reduced, there is an 
ultimate accumulation of fat stores in the animal. When an animal is starved, increase 
lipase expression frees fatty acids from TAG stores, so they can be oxidized for ATP 
production. Under well-fed conditions, high levels of malonyl-GoA inhibit the transport of 
fats to the mitochondria and prevent their breakdown. 
Targeting Fatty Acid Metabolism Pathways 
In order to treat obesity, there have been many attempts to establish drugs that target 
various aspects of fatty acid metabolism. The majority of developed therapies have been 
unsuccessful and/or have been withdrawn as treatments due to the danger of side-effects 
(Ioannides-Demos et aI., 2011). So far, only one drug, orlistat, is approved for long-term 
obesity treatment. Orlistat (also known as Alii) inhibits the activity of pancreatic and gastric 
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lipases which results in an -30% reduction in fat absorption and an overall reduction in body 
mass (Shi et aI., 2004). 
Because fat synthesis can also contribute to overall fat stores, a number of drugs that 
can target fatty acid synthase effectively have been explored in animal models. Fatty acid 
synthase inhibitors like cerulenin and C75 have shown promise in animal studies; however, 
they have limited utility as a therapy in humans due to low stability, low bioavailability and/or 
undesirable side-effects (Menendez et aI., 2007). In particular, a major challenge to 
inhibiting fatty acid synthase is the established role for fatty acid synthesis in reproduction 
and other undiscovered functions for this pathway. 
Additionally, the mechanism of fat storage reduction is not clear upon fatty acid synthase 
inhibition. One leading hypothesis that has been proposed is that the reduction in fat stores 
in treated animals occurs due to the buildup of products like malonyl-CoA which can 
suppress the appetite (Shi et aI., 2004). Nevertheless, a better understanding of how fat 
metabolism pathways are regulated and how they interact will be critical for the development 
of viable therapies. 
Relationships Between Metabolism, Reproduction and Lifespan 
Not only does the total amount of fat storage impact an animal's health and lifespan, but 
how nutrients are utilized can also have dramatic affects. In times of growth and 
reproduction, there are added demands on dietary resources, and these added strains might 
impact the availability of resources for other processes. The best example of such tradeoffs 
is the general observation in the aging field that animals with increased longevity tend to 
have reduced fecundity. This "cost of reproduction" is thought to result from multiple 
processes competing for the same resources. Therefore, as the demands for offspring 
production increase, there are fewer resources available for somatic maintenance and 
repair, growth and movement (Partridge et aI., 2005). Two of the most well studied lifespan 
extension mechanisms are reduced insulin/IGF-1 signaling and dietary restriction, which are 
known to increase lifespan in C. elegans, Drosophila, and rodent models. As well as 
increasing lifespan, these animals also have delayed and/or reduced fecundity. 
Interestingly, in Drosophila, increased nutrient availability drives an increase in reproductive 
activity (Piper et aI., 2005). Although there is evidence for a relationship between 
metabolism, reproduction and aging, further studies are needed to establish how these 
processes impact each other. 
5 
Altered Fatty Acid Metabolism in Cancers 
In normal cells, the majority of fatty acids are derived directly from the diet; however, in 
cancer cells, almost none of the fatty acids are dietary in origin (Ookhtens et aI., 1984). 
Increased expression of the FASN gene has been found in the majority of cancers tested 
including prostate, breast, lung and gastric cancers (Flavin et aI., 2011; Kusakabe et aI., 
2002; Menendez et aI., 2007). In cancer cells, fatty acid synthase is not susceptible to 
normal repressive mechanisms and, although FASN is normally downregulated by fat in the 
diet, fat synthesis in cancers functions independentof dietary cues (Kuhajda, 2000). The 
elevated fatty acid synthase expression seems to convey an advantage to cancer cells as 
elevated FASN expression is correlated with increased metastasis and poor prognosis. 
The increase in de novo fatty acid synthesis seen in cancers may be directly connected 
to the glycolytic metabolism of the cancer cell. The vast majority of tumors rely almost 
exclusively on sugar-based metabolism as first described by Otto Warburg in the 1920s 
(Warburg et aI., 1927). The aerobic glycolysis driven metabolism results in an imbalance of 
the NADH:NAD+ ratio, which can be alleviated by the function of lactate dehydrogenase or 
by de novo fatty acid synthesis. Additionally, it has been suggested that the increase in 
lipogenesis is also important for the generation of membranes for the rapidly dividing cancer 
cells. Regardless of its exact function, it is clear that de novo synthesis provides the tumor 
with an advantage, and inhibition of FASN results in apoptosis in tumor cell lines (Horiguchi 
et aI., 2008; Pizer et aI., 1998). Additionally, FASN inhibition in mouse models results in 
tumor growth inhibition and suppression of metastasis (Flavin et aI., 2011; Murata et aI., 
2010). Because of the susceptibility of cancers to FASN inhibition, many studies in animal 
models have focused on the potential for treatment of cancers with FASN inhibitors; 
however, there has not been any successful FASN inhibitors trials in humans as of yet. 
C. e/egans as a Model for Studying Fat Metabolism 
A complete understanding of the genetic regulation of metabolism requires a genetically 
tractable model to deconvolute complex pathway dynamics. The nematode, C. e/egans, 
has recently been established as a model for studying genetic regulation of fat storage. 
Many core metabolic pathways including food intake, digestion, fatty acid synthesis, fatty 
acid processing, glycolysis, ~-oxidation and lipid signaling are conserved between 
nematodes and mammals (Mullaney et aI., 2009). Because C. e/egans has been 
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successfully used to elucidate genetic pathways and to screen for unidentified regulators, 
there has been a growing interest in using the nematode to understand how genes and the 
environment impact fat storage and metabolism. To do this, a number of tools have been 
established to monitor fat storage in the animals including lipophilic dyes, fat analysis by gas 
chromatography/mass spectrometry and direct imaging by CARS microscopy (Ashrafi et aI., 
2003; Brock et aI., 2006; Hellerer et aI., 2007; Yen et aI., 2010). Additionally, qRT-PCR 
panels have been established to monitor the expression levels of metabolic enzymes (Van 
Gilst et aI., 2005). 
The nematode also has many genetic tools that make defining genes and pathways that 
regulate various aspects of fatty acid metabolism feasible. For example, genome-wide 
RNAi screens have identified over 400 genes that influence total fat accumulation (Ashrafi et 
aI., 2003). Of the genes identified in that screen, over 50% have human homologs that have 
not been implicated in fat metabolism previously. Additionally, the short generation time and 
lifespan of the animal makes it possible to monitor different aspects of fat metabolism over 
development (egg to egg in 72 hours) and over aging (mean lifespan is 2-3 weeks). 
Although C. e/egans has been a useful model for studying fat metabolism, there was a 
need for the development of new methodology. Not only has the validity of some of the 
current tools for monitoring fat storage been called into question, but there is also a need for 
novel ways to monitor how the animal obtains and distributes fatty acids (O'Rourke et aI., 
2009; Yen et aI., 2010). Therefore, the establishment of an improved method for studying 
fatty acid metabolism in the nematode was needed in order to approach many of the topics 
discussed here. 
Metabolomic Analysis 
Because many aspects of fatty acid metabolism are impacted by numerous pathways, 
transcriptional analyses can be difficult to interpret. Therefore, metabolic flux data is 
important to directly assess the rate of synthesis and breakdown pathways. Traditionally, in 
order to quantify lipogenesis, de novo fatty acid synthesis is quantified by the incorporation 
of a radio-labeled precursor in the diet and detection of the label in the fats of the animal. 
Although strategies based on radio-labeling are very sensitive, there is limited data collected 
on synthesis in different fatty acid species and lipid classes. In order to quantify fatty acid 
synthesis with greater resolution, we wanted to implement stable isotope techniques that 
require high enrichment of the stable isotopes. The requirement of greater levels of 
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enrichment makes this type of study prohibitively expensive in mammalian systems. The 
nematode C. e/egans allows for high stable isotope enrichment that allows us to answer 
many questions about fatty acid synthesis simultaneously. We have developed a mixed 
stable 13C isotope labeling approach that allows us to monitor fatty acid synthesis in various 
conditions and genetic backgrounds, making it possible to use nematodes to increase the 
understanding offatty acid synthesis (Perez et aI., 2008). 
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Figure 1.1. Fatty Acid Metabolism and Partitioning: Fatty acids can be 
absorbed directly from the diet or synthesized de novo from dietary 
carbohydrates. Together, these pathways generate a pool of fatty acids which 
is then allocated to a number of physiological fates: phospholipid synthesis, 
triglyceride synthesis and p-oxidation. Fatty acids are also important 
components of many signaling pathways, but the amount of fatty acid used in 
signaling pathways is relatively minimal. 
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Figure 1.2. Sugar and Lipid Metabolism Pathways: To produce energy, 
fatty acids and sugars can be broken (by r.,-oxidation and glycolysis, 
respectively) into acetyl-CoA molecules. These acetyl-CoA's then feed the 
TCA cycle resulting in the production of substrates to drive oxidative 
phosphorylation. When fatty acid production is required, de novo fatty acid 
synthesis can generate fatty acids from acetyl-CoA molecules. In the 
nematode, the glyoxylate pathway (represented by the dashed line) can 
convert fats to sugars by bypassing CO2-production steps in the TCA cycle. 
Figure adapted from Ashrafi K (2007). 
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Figure 1.3. Faty Acid Synthesis, Elongation and Desaturation Pathway: 
(A) Fatty acid synthesis requires two enzymes: (I) acetyl-GoA carboxylase 
which generates malonyl-GoA (the extender) and (II) fatty acid synthase 
(FASN) which catalyzes the condensation reaction and results in chain 
elongation. To generate one fatty acid (G16:0), this reaction consumes 1 
acetyl-GoA, 7 malonyl-GoA's, 14 NADPH's and 14 H+. (8) The G16:0 can 
then be elongated and desaturated to form fatty acids of various lengths and 
degrees of saturation. The elongases (e/o genes) and desaturates (fat genes) 
catalyze these reactions in C. e/egans. The fatty acid nomenclature used 
here is GX:anb, with "X" indicating the number of carbons in the fatty acid, "a" 
representing the number of double bonds and "b" indicating the position of the 
double bond. 
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CHAPTER II: A Stable 13C Labeling Strategy for Detection and Quantification of de 
novo Synthesized Fatty Acids in C. eJegans 
Modified from an article published in Cell Metabolism: 
Perez CL and Van Gilst MR. (2008). A 13C isotope labeling strategy reveals the influence of 
insulin signaling on lipogenesis in C. elegans. Cell Metabolism Sep;8(3):266-274. 
Summary 
Metabolic flux analysis allows for the understanding of how multiple pathways are ,integrated 
onto the core metabolism of an animal as it encounters different environmental and 
physiological challenges. Here, we have developed and implemented a stable 13C isotope 
approach that allows us to monitor how the animals are utilizing their diet. We have 
developed a "mixed isotope" strategy to specifically quantify various aspects of fatty acid 
metabolism, and we have found that we can accurately determine whether the fats of the 
animals are absorbed directly from the diet or synthesized de novo. Using this 13C mixed 
isotope assay, we have determined that de novo synthesis can contribute to the generation 
of each species of fatty acid except for the bacterial cyclopropyl fatty acids. However, the 
contribution of de novo synthesis is minimal in most fat species similar to what is seen in 
mammalian systems as most fat is obtained directly from the diet. We have further 
validated this strategy by quantifying fatty acid synthesis in nematodes predicted to have 
altered fat synthesis, absorption and expenditure due to genetic mutations or drug 
treatment. With this analysis, we have found that our assay can distinguish the fat 
metabolism profile in each instance. This mixed isotope labeling strategy will allow the 
utilization of the nematode, C. elegans, as a model for studying the genetic regulation of de 
novo fatty acid synthesis and fat absorption. 
Introduction 
Excess fat storage increases an individual's likelihood of developing a number of 
prevalent diseases including Type" diabetes, hypertension, and even many cancers (Wang 
et aI., 2011; Watts, 2009). This impact of fatty acid metabolism on overall health has 
resulted in many attempts to alter metabolic pathways pharmacologically; however, these 
efforts have been largely unsuccessful to this point largely because a better understanding 
of these pathways is needed. In addition to behavioral and environmental factors, it is clear 
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that genetic background plays a substantial role in determining the propensity for obesity 
and related complications (McPherson, 2007). Consequently, there is considerable interest 
in defining genes that affect the partitioning of dietary nutrients for fat storage. Because the 
genetics of obesity are complex and multifactorial, model systems have been important tools 
for defining genes and pathways that impact fat storage. Studies in C. elegans have 
characterized numerous pathways that modulate lipid accumulation, including insulin/IGF, 
serotonin, tubby, and nuclear receptor signaling (Mukhopadhyay et ai., 2005; Ogg et ai., 
1997; Sze et ai., 2000; Van Gilst et ai., 2005). Furthermore, a genome-wide RNAi screen 
isolated over 400 genes that influence total fat accumulation, many of which have not been 
previously implicated in the regulation of fat metabolism (Ashrafi et ai., 2003). 
In principle, genes could alter fat storage by modulating three factors: (1) how much fatty 
acid is ingested and absorbed from the diet, (2) how much dietary nutrient is converted to fat 
via de novo lipogenesis, and (3) how much fat is expended through [3-oxidation. Because 
little is known about these processes in nematodes, the ability to elucidate the mechanisms 
of fat regulatory genes in C. elegans has been limited. For example, mutations of the insulin 
receptor gene, daf-2, can increase lifespan and fat storage through inappropriate activation 
of the FoxO transcription factor DAF-16. Microarray studies have shown changes in the 
expression of numerous genes predicted to participate in fatty acid metabolism, but it is still 
not clear how DAF-2 and its regulatory targets actually modulate fat synthesis, absorption, 
and/or expenditure (Halaschek-Wiener et ai., 2005; McElwee et ai., 2003) 
In order to better understand the mechanisms by which the insulin receptor and other 
regulatory genes regulate lipid physiology in C. elegans, it is essential to develop methods 
for characterizing and quantifying fatty acid metabolism. Stable isotope-based experiments 
have been employed to monitor fatty acid flux in numerous biological systems 
(Brunengraber et ai., 1997; Kelleher, 2001; McCabe et ai., 2004; Murphy, 2006; Strawford et 
al.,2004). Furthermore, isotope labeling of food has been applied to globally monitor 
macronutrient partitioning in an invertebrate model organism, Drosophila melanogaster (Min 
et ai., 2006) and (O'Brien et ai., 2008). Here, we present a 13C isotope-labeling approach to 
characterize dietary fat absorption and fatty acid synthesis in C. elegans for the first time. 
We utilize this metholodogy to determine how known regulatory pathways like insulin 
signaling influence these central aspects of lipid metabolism. 
A 13C Enrichment Strategy to Identify and Quantify Dietary and De Novo Synthesized 
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Fatty Acids 
We designed a "mixed isotope" assay to quantify the relative contributions of de novo 
synthesis and dietary fat absorption to the total lipid composition in C. elegans (Figure 2.1). 
In principle, animals that are fed a mixture (1:1) of 13C-enriched E. coli (OP50) and 
unlabeled bacteria should obtain approximately half of their nutrients from 13C-labeled 
bacteria and half of their nutrients from unlabeled 12C bacteria. Therefore, using this 
strategy, fats absorbed from the diet and directly incorporated into worm lipids will either be 
fully composed of 13C (if directly obtained from labeled bacteria) or fully composed of 12C (if 
absorbed from unlabeled bacteria). In contrast, fats synthesized de novo in C. elegans will 
contain a statistically definable mixture 12C and 13C since synthesis substrates will be 
derived from the breakdown of labeled and unlabeled bacterial nutrients. The relative 
contributions of dietary fatty acid absorption and de novo synthesis can therefore be 
quantified by analyzing the molecular weight (MW) distribution of purified fatty acids by gas 
chromatography/mass spectrometry (GC/MS). 
We prepared mixed isotope "feeding plates" by plating a 1:1 mixture of bacteria grown in 
standard unlabeled media, and bacteria grown in 13C-enriched media (lsogro-13C Powder 
Growth Media from Sigma-Aldrich). To confirm the isotope composition of the fatty acids in 
our feeding plates and to ensure that there was no cross contamination during the labeling 
assay, we independently analyzed bacterial fatty acids from the feeding plates for each 
experiment. To do this, we collected bacteria directly from the mixed label feeding plates, 
extracted the bacterial fatty acids and generated a mass spectrum for palmitate (C16:0) by 
GC/MS. It is clear from these data that there are no quantifiable peaks in the "synthesized 
region" of the mass spectrum (Figure 2.2A). The shoulder peaks present at 271-272 and 
284-285 are a consequence of natural 13C abundance or 12C contamination in our 13C 
bacterial growth media. In nature, 12C is 98.9% abundant, and the probability of 
incorporating 13C into a palmitate methyl ester was determined using a binomial distribution 
(Kelleher,2001). Similarly, we calculated the isotope purity of our 13C bacteria enrichment 
by comparing the fractional abundance of the isotopic peaks at 284 and 285 Daltons (Figure 
2.2A). On average, we found that the 13C enrichment of our Isogro media was 98.5% in 
agreement with manufacturer's specifications. These data confirmed that for the period in 
which the bacteria reside on the feeding plates, there was no detectable incorporation of 
contaminating carbon sources, other than natural isotope variation. Thus, dietary fatty acids 
available to worms grown on mixed isotope feeding plates were either 98.5% composed of 
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13C or 98.9% composed of 12C. 
The primary dietary fatty acid in bacteria is C16:0 (Table 2.1), and, because C16:0 is 
also the product of de novo fatty acid synthesis, we first applied our technique to 
characterize C16:0 synthesis and absorption. The mass spectrum of C16:0, obtained from 
worms grown on a mixed isotope feeding plate, revealed C16:0 species with a range of 
MWs (isotopomers), from 270 Daltons (for a palmitate methyl ester fully composed of 12C) to 
286 Daltons (for a palmitate methyl ester fully composed of 13C) (Figure 2.28). To derive a 
quantitative model to fit these data, we considered that C16:0 was obtained from four 
sources (Figure 2.28). First, dietary absorption: intact C16:0 taken up from unlabeled 
bacteria and incorporated into worm lipids displayed a MW of 270 Daltons, whereas C16:0 
directly absorbed from 13C-enriched bacteria contributed to the isotopomer peak at 286 
Daltons (shoulder peaks due to isotope impurities were accounted for in our analysis). 
Second, C16:0 could be formed in C. e/egans by elongation of dietary C14:0; molecules 
generated in this fashion would fall between 270-272 Daltons and 284-286 Daltons (Figure 
2.4). Third, C16:0 could be derived from de novo synthesis; fatty acids produced by 
synthesis will display an isotope-labeling pattern that falls into a trinomial distribution, which 
will depend on the probability of incorporating acetyl-CoA units that are 12C_12C, 12C_13C, or 
13C_13C (See Experimental Procedures). Although these probabilities could be determined 
by fitting the isotopomer data, we were able to independently determine the acetyl-CoA 
isotopomer distribution by measuring the elongation of C16:0 to C18:0 (Figure 2.3). Finally, 
since our assays were carried out by placing unlabeled larvae (L 1 stage) on mixed isotope 
bacteria, maternally derived C16:0 that remains in harvested L4 stage animals also 
contributed to the isotopomer peak at 270 Daltons. Although we can assume the maternally 
derived fatty acids by accounting for all the other sources of unlabeled C16:0 (MW of 270 
Daltons), we also independently confirmed the amount of fatty acid derived from maternal 
sources. To do so, we grew newly hatched animals (L 1 s) on fully labeled bacteria (98.5% 
13C) until mid-L4 (Figure 2.5). This analysis confirmed the maternal contribution to palmitate 
is about 5% in the L4 animal. 
Taking into account these four possible sources of palmitate, we derived a mathematical 
model to fit the mass distribution (Figure 2.28, see Experimental Procedures for a 
description of the data analysis). Our model revealed that the majority of C. e/egans C16:0 
was derived from direct absorption of bacterial fatty acid. However, de novo synthesis did 
account for 7% of total palmitate. 
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Origin of Other C. e/egans Fatty Acid Species 
Our findings revealed that dietary fat absorption is the primary source of worm palmitate; 
however, C. elegans contains numerous other types of fatty acids, some of which are not 
found in its bacterial diet (Table 2.1). Stearate (C18:0), oleate (C18:1n9), linoleate 
(C18:2n6), and several 20 carbon polyunsaturated fatty acids (PUFAs) are not available in 
the common laboratory diet (E. coli [OP50]) and must be obtained by elongation and 
desaturation of C16:0 (Figure 2.6) (Watts et aI., 2002). Although synthesis accounted for 
only 7% of the steady-state levels of C16:0, we found a more predominant role for de novo 
synthesis in the production of monounsaturated fatty acids (MUFAs) and PUFAs (up to 19% 
of total fatty acid) (Figure 2.6). Twenty carbon fatty acids could not be assessed by our 
method due to extensive fragmentation of these molecules in the mass spectrometer. 
We also found that C. elegans monomethyl branched-chain fatty acids (mmBCFAs), 
C151S0 and C171S0, were >99% derived from de novo synthesis. The mmBCFAs are 
generated by the elongation of a branched chain primer by fatty acid synthase, and these 
fatty acids have been established to be essential for proper nematode development and 
growth (Kniazeva et aI., 2004). mmBCFAs are not present in the OP50 diet and cannot be 
produced from modification of bacterial fatty acids. For these reasons, it has been proposed 
that mmBCFAs must be derived from de novo synthesis (Kniazeva et aI., 2004); our results 
provide direct biochemical confirmation of this hypothesis. In contrast, four C. elegans fatty 
acid species, vaccenate (C18:1n7), palmitoleate (C16:1n7), and two cyclopropane fatty 
acids (C1711 and C1911), are prevalent dietary fats. We found that 95% ofC18:1n7 and 
C16:1 n7 and >99% of the cyclopropyl fatty acids originate from direct absorption of the 
bacterial fatty acid (Figure 2.6). 
Synthesized Fatty Acids Are Distributed Equally to Triglycerides and Phospholipids 
De novo fatty acid synthesis contributes more prominently to the generation of MUFAs 
and PUFAs, which are major phospholipid species in the nematode. Therefore, we 
considered the possibility that synthesized fatty acids may be funneled preferentially to 
phospholipid formation. To test this hypothesis, we purified triglycerides (TAG) and 
phospholipid (PL) fractions from mixed labeled worms. We found that for each fatty acid 
species, the relative amount of de novo synthesis is equivalent for TAG and PL (Figure 2.7). 
For example, the linoleate (C18:2n6) associated with either TAG or PL is about 18% derived 
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from de novo synthesis. This indicates that synthesized fatty acids are not preferentially 
allocated to phospholipid synthesis but instead contribute to the generation of the fatty acid 
pool which is then used to supply phospholipid and triglyceride synthesis. 
Biochemical Confirmation of Increased Synthesis in Insulin Signaling Mutants 
We next sought to implement this mixed labeling assay with mutants that are predicted 
to regulate de novo fatty acid synthesis. In C. elegans, mutations in the insulin receptor 
gene, daf-2, have been shown to regulate lifespan and fat storage through the inappropriate 
activation of the FoxO transcription factor, DAF-16. Additionally, microarray analysis of daf-
2 mutants has revealed gene expression changes in numerous genes predicted to 
participate in fatty acid metabolism (Halaschek-Wiener et aI., 2005; McElwee et aI., 2003; 
Murphy et aI., 2003). Although increased fatty acid synthesis has been predicted as the 
major influence of fat storage in daf-2 worms, it is not clear how DAF-2 and it regulatory 
targets actually modulate fat synthesis, absorption, and/or expenditure. 
To determine the mechanism of fat accumulation, we implemented a mixed isotope 
labeling assay on daf-2(e1370) worms. In these animals, we found that there is a significant 
increase in the proportion of fatty acids derived from de novo fatty acid synthesis, 
suggesting that increased fat storage is due largely to elevated lipogenesis (Figure 2.8). We 
also established that this elevated synthesis is dependent on the function of the DAF-16 
transcription factor as daf-2(e 1370);daf-16(m26) double mutants displayed levels of fatty 
acid synthesis that were slightly lower than WT animals (Figure 2.8). Furthermore, mutation 
of daf-16(m26) alone resulted in a slight reduction in de novo synthesis. Taken together, 
these results imply that DAF-16 stimulates fatty acid synthesis, and that activation of the 
insulin signaling pathway represses synthesis, at least in part, by inhibition of daf-16. The 
role of the insulin signaling pathway in regulating de novo fatty acid synthesis is further 
discussed in Chapter 3. 
Decreased Fat Absorption in Triglyceride Lipase Inhibited Animals 
Because this method allows us to track both dietary and synthesized fats in the 
nematode, we next wanted to assay the ability of this stable isotope strategy to discern 
changes in dietary fat absorption. To do this, we treated nematodes with orlistat to reduce 
dietary fat absorption. Orlistat is a gastric and pancreatic lipase inhibitor that has been 
found to reduce dietary fat absorption by 30% in humans (Drew et aI., 2007). In these 
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animals, we found a dose-dependent increase in the ratio of synthesized to absorbed fatty 
acids. The largest change observed is seen with treatment at 50 iJM with a 2.5x increase in 
relative palmitate synthesis when compared to untreated animals (Figure 2.9A). 
Because the ratio of synthesized to absorbed fatty acids will increase when synthesis is 
increased or when absorption is decreased, we next measured the total amount of fat 
storage to distinguish these possibilities. With increased fatty acid synthesis, the total 
amount of fat will increase leading to an overall increase in fat storage; however, with 
decreased absorption, the total fat will decrease resulting in a decreased TAG:PL ratio. To 
assay fat storage, we purified TAG and PL populations by column chromatography and 
compared the relative abundance of fat storage triglycerides using internal standards. We 
found that treatment with orlistat results in a 47% decrease in TAG:PL suggesting that the 
amount of fatty acid absorption is decreased, consistent with inhibition of TG lipase activity 
(Figure 2.9B). 
Orlistat has been found to have additional inhibitory effects on fatty acid synthase; 
however, when we assay the fatty acid composition of the orlistat treated animals, we found 
decreased abundance of dietary fats and increased relative abundance of de novo 
synthesized fats, the monomethyl branched chain fatty acids, suggesting that the primary 
impact of orlistat is the triglyceride lipase inhibition, at least in the nematode (Figure 2.9C). 
Our findings with orlistat treated worms confirmed that the mixed isotope assay could 
identify changes in dietary fat absorption. Additionally, the efficacy of orlistat in the 
nematodes provides an example of the homology of fat metabolism pathways in nematodes 
and mammals and opens the possibility for studying the impacts of various drugs on fat 
metabolism in worms. 
No Change in Isotope Distribution in Mutants with Decreased ~-Oxidation 
Finally, the remaining contributor to fat storage is fat utilization by mitochondrial ~­
oxidation. We used nhr-49(nr2041) animals which are known to have decreased expression 
of ~-oxidation genes to determine if we can see any changes in isotope distribution (Van 
Gilst et ai., 2005). In these nhr-49 animals, we detected no change in the ratio of 
synthesized to dietary fatty acids in all fatty acid species measured (Figure 2.10). Because 
these animals are high in lipid storage without an increase in de novo fat synthesis or dietary 
fat absorption, it implies that the increased fat accumulation is due to a failure to oxidize the 




Using a 13C isotope-labeling strategy, we have provided a thorough description of how 
C. elegans obtains and distributes fatty acids. Elegant stable isotope approaches have been 
used to measure lipid metabolism in other animal models including humans; what 
distinguishes this method, however, is that the entire carbon component of a natural food 
source is labeled, enabling simultaneous monitoring of fatty acid absorption, elongation and 
desaturation, and de novo synthesis. Thus, multiple aspects of nutrient utilization and lipid 
metabolism can be examined in a single assay with an exceptional degree of detail and 
precision. Additionally, this approach can survey metabolism over the entire course of 
development and adulthood; thus, the long-term impact of genetic mutations and dietary 
manipulations can be readily assessed in high-throughput fashion. We expect this general 
strategy to be applicable for investigating many different metabolic pathways in C. elegans, 
as well as other model organisms. 
We found that worm fatty acids are derived from four sources: (1) direct absorption and 
incorporation of dietary fats, (2) absorption and modification of dietary fats by elongation 
and/or desaturation, (3) de novo synthesis, and (4) maternal inheritance. When grown on 
the OP50 strain of E. coli, a standard laboratory diet, the majority of fatty acids are directly 
obtained from ingested bacteria. However, de novo synthesis is not a negligible factor, 
contributing especially to species not available in the diet, such as C18:0 (13%), C18:1n9 
(17%), C18:2n6 (19%), and mmBCFAs (>99%). Presumably, worms will modify fatty acid 
synthesis and absorption patterns to accommodate food sources with different lipid 
compositions. The fact that the relative contribution of de novo synthesis and dietary fat 
absorption was similar in PLs and TAGs implies that dietary and synthesized fats freely 
diffuse through the worm such that a common pool is used for the majority of PL and TAG 
synthesis. 
We believe a major advantage of the mixed isotope strategy in nematodes is its ability to 
define how different genes impact overall fat storage. In order to validate our strategy and 
to demonstrate the versatility of the mixed isotope assay, we characterized mutants and 
conditions predicted to regulate aspects of de novo fatty acid synthesis and dietary fatty acid 
absorption. Our success characterizing the impact of genes and drug treatments on fat 
synthesis indicates that this mixed isotope assay will be a useful tool in characterizing how 
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genes and drugs impact fat metabolism. Additionally, we can also use this assay to screen 
for novel regulators of fat synthesis and fat absorption (discussed in Appendix I). 
Experimental Procedures 
Strains 
Worm maintenance and experiments were carried out at 20°C. In these experiments, the 
following strains were obtained from the Caenorhabditis Genetics Center CGC: wild-type 
N2 strain (Bristol), CB1370: daf-2(e1370), DR1309: daf-2(e1370);daf-16(m26) and DR26: 
daf-16(m26). nhr-49 (nr2041) was a gift from Carl Johnson at Axys Pharmaceuticals. 
Growth on Mixed Isotope Feeding Plates 
To prepare mixed isotope feeding plates, separate 12C_ and 13C-enriched cultures were 
started by inoculating LB C2C media) and Isogro media (98.5% 13C enriched; from Sigma-
Aldrich) with E. coli (OP50). Cultures were grown for 16 hr at 37°C, harvested by 
centrifugation, washed, and then combined 1:1, by weight, in M9 buffer. This mixture was 
spread onto 15 cm agarose plates (1.5% agarose, 50 mM NaCI, 1 mM CaCI2, 1 mM MgS04 , 
and 25 mM KP04 , pH 6.0 buffer). Agarose plates prevent bacterial growth and, thus, the 
incorporation of exogenous carbon. For labeling assays, 30,000 synchronized L 1 larvae 
were prepared by bleaching gravid adults and allowing embryos to hatch in the absence of 
food (Van Gilst et aI., 2005). 20-24 hr after bleaching, L 1 s were plated on mixed isotope 
feeding plates and collected after 44-48 hr of feeding (worms were harvested as mid-L4 
larvae). All experiments were carried out at 20°C. 
Orlistat Inhibition 
An orlistat master stock (from Sigma-Aldrich) was prepared at 13.5 IJg/ml in ethanol. In 
order to spread the drug on NGM plates effectively to the final concentration between 5nM 
and 501JM, the total volume was increased to 600IJI with 1X M9 buffer. We assumed each 
6cm plate contains approximately 6ml of media for calculations of the correct drug 
concentration. Plates were allowed to dry for a minimum of 30 minutes before use. For 
synthesis analysis, OP50 was also plated on orlistat and the treated bacteria were used to 
establish the correction factor for these studies. 
Lipid Purification and Analysis 
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For whole-worm fatty acid analysis, total lipids were extracted and converted to fatty acid 
methyl esters (FAMEs) as described (Watts et aI., 2002). For PL and TAG purification, total 
lipids were extracted with 2:1 chloroform:methanol for 1 hr at room temperature. Next, 0.2 
volumes of 0.9% NaGI were added and the mixture was vortexed and allowed to separate 
for 2 min. The top layer (aqueous) was removed and the bottom layer was dried down 
under nitrogen. Dried lipids were resuspended in 1 ml of chloroform. Calibrated 
phospholipid standard (1 ,2-Dihepatdecanoyl-sn-Glycero-3-Phosphocholine, Avanti Polar 
Lipids) and TAG standard (tritridecanoin, Nu-Chek Prep) were added to the total lipid 
mixture before extraction. PLs and TAGs were purified by solid phase exchange (SPE) 
chromatography. Extracted lipid was resuspended in chloroform and loaded onto SPE 
columns (100 mg capacity, Fisher Scientific) pre-equilibrated with 3 ml of chloroform. TAGs 
were eluted first with 3 ml of chloroform. Glycosphingolipids were eluted next with 5 ml of a 
9:1 acetone:methanol mixture, and phospholipids were eluted last with 3 ml of methanol. 
Purified lipids were dried, resuspended in methanol/2.5% H2S04 , and incubated for 1 hr at 
80 0 G to create FAMEs. 
FAMEs were analyzed by gas chromatography/mass spectrometry (GC/MS) (Agilent 
6890GG, 5975MS). Isotopomers were monitored in a scanning ion mode customized to 
each fatty acid species of interest; for example, G16:0 MS scans ranged from m/z = 265 to 
m/z = 290. To quantify TAG and PL yields, total PL and TAG were compared to the 
internally added standards. Data were presented as a TAG:PL ratio, which was determined 
by measuring the sum of all fatty acids found in TAGs versus the sum of all fatty acids found 
in PLs (Ashrafi et aI., 2003). 
The relative abundance of each fatty acid species was determined by integrating the area of 
each fatty acid peak in the gas chromatograph. Fatty acids comprising less than 2% of the 
total fatty acid were not included in the analysis. 
Evaluation of Feeding Plate Isotope Composition, Enrichment, and Purity 
For each experiment, the isotope composition of the feeding plates was independently 
characterized. To do this, a portion of the 1: 1 feeding mixture was allocated to a "control" 
feeding plate. This plate was incubated at 20 0 G in the absence of worms for the entire 
course of the experiment. Bacteria were collected from these control feeding plates, total 
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lipid was extracted, transmethylated, and analyzed by GC/MS according to the same 
procedures described above. 
We also used the feeding plate GC/MS data to calculate the relative ratio of labeled to 
unlabeled bacterial fatty acid on each set of feeding plates. Although we were careful in our 
efforts to mix bacteria equally by weight, we found that our cultures were generally not 
composed of an exact 1:1 mixture. The ratio of fully labeled to fully unlabeled palmitate was 
often skewed such that there was a slightly higher supply of unlabeled fatty acids, relative to 
labeled fatty acids (Figure 2.2). For this reason, it was necessary for us to quantify the 
isotope composition of the bacterial mixture on each set of feeding plates. This information 
was used to establish a correction factor (CF) for calculations described below. 
Calculating the Biosynthetic Origins of Palmitate 
To model the mass spectra data, we developed mathematical terms to account for four 
potential origins of fatty acids in C. e/egans: (1) de novo fatty acid synthesis, (2) direct 
dietary absorption, (3) absorption and elongation of dietary fatty acid, and (4) maternal 
inheritance. For palmitate methyl esters, we used Equation 1 to model total isotopomer 
abundance. 
(1) In(Tot) = In(Synth) + In(Abs) + In(Elong) + 1n(Mat), n=270, ... ,286 
where In is equal to isotopomers with a MW of n Daltons. In(Tot) represents total abundance 
of each isotopomer. In(Synth) equals the abundance of isotopomers resulting from de novo 
synthesis. In(Abs) is equal to isotopomers resulting from directly absorbed C16:0. In(Elong) 
represents isotopomers that were generated by elongation of dietary C14:0, and In(Mat) 
takes into account fatty acids supplied by maternal contribution. 
Corrections for 12C Isotope Impurity in Labeled Media and Natural 13C Abundance 
To begin our analysis, we first determined the abundance of isotopomers due to isotope 
impurities. Impurity abundance was calculated for 1271, 1272, 1273, 1283, 1284, and 1285 using 
standard binomial distributions (Kelleher, 2001). For our calculations, we used 1.11 % as the 
natural 13C abundance in the unlabeled fatty acids, and 1.5% as the 12C contamination in the 
labeled fatty acids (see above and Figure 2.2). Isotopomer abundance resulting from 
22 
isotope impurity was then subtracted from the data in order to perform the calculations 
described below. At the end of our analysis, when In(Abs), In (Elan g) , In(Synth), and In(Mat) 
were determined, isoto po mer impurity abundances were then assigned to each of the above 
terms and added back to create the final model (Figure 2.3). Isotope impurity corrections 
were not used for isotopomers between 273 and 283 Daltons because the probability of 
obtaining a dietary fatty acid with MWs in this range is insignificant (Figure 2.2) and because 
isoto po mer peaks resulting from fatty acid synthesis are modeled by acetyl-CoA 
composition calculations, which take into account both isotope dilution and isotope impurity 
(see below). 
Determining In(Synth): Isotopomer Abundance due to Fatty Acid Synthesis 
To model the contribution of de novo synthesis to C16:0 isotopomer abundance, we 
considered that C16:0 will be synthesized from eight acetyl-CoAs, and that these two-
carbon substrates will be composed of 12C_12C, 12C_13C, or 13C_13C. Therefore, the MW of a 
synthesized C16:0 molecule will depend on the specific number of C2C-12C) substrates, 
C2C-13C) substrates, and C3C_13C) substrates, termed A, B, and C, respectively, 
incorporated into that molecule. Since a total of eight two-carbon units are used to 
synthesize a C16:0 molecule, the specific number of each substrate will range from 0 to 8, 
and the sum of A, B, and C must be 8. Thus, a population of synthesized C16:0 will yield an 
isotopomer distribution that depends on the relative fractions of 12C_12C, 13C_12C, and 13C_13C 
substrates. The following trinomial expression was used to model the isotopomer 
d istri bution: 
(2) 
where Pa equals the probability of incorporating a [12C_12C], Pb equals the probability of 
incorporating a [13C_12C], and Pc equals the probability of incorporating a C3C-13C]. Although 
Pa, Pb , and Pc could be theoretically determined by fitting the isotopomer data, we were able 
to experimentally measure these values directly by examining the elongation of C16:0 to 
C18:0 (see next section). Next, the probability of each combination of A, B, and C was 
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These probabilities were then used to model the contribution of de novo synthesis to the 
isotopomer distribution using the following equation: 
(4) In(Synth) = (NF * Pn) 
where Pn represents the probability of obtaining an isotopomer with MW of n, and NF is a 
normalization factor that translates the probability of obtaining each isotopomer into total 
isotopomer abundance. The NF was determined by the following equation: 
(5) NF = '276(Tot)/P276 
The 1276 peak was used for normalization because this isotopomer is exclusively derived 
from synthesized fatty acid molecules; therefore '276(Tot) is equal to 1276(Synth). Because our 
feeding mixture generally contained higher levels of 12C bacteria and because worms also 
carried 12C derived from the mother, two carbon units carried a disproportional amount of 
12C, causing the synthesis distributions to be skewed toward "lighter" isotopomers. This was 
well modeled by our analysis (Figure 2.3). Importantly, our data were also well modeled 
using experimental determination of Pa, Pb , and Pc. The ability of experimentally measured 
probability values to correctly fit our synthesis data provides independent confirmation of the 
analysis. 
Modeling In{Elong): The Contribution of Dietary Fat Elongation to Isotopomer 
Abundance 
In our palmitate mass spectra, even after removal of peaks due to isotope impurity, we 
conSistently observed peaks at 272 and 284 Daltons that were significantly bigger than 
would be expected from synthesized palmitate (Figure 2.3). We deduced that these peaks 
resulted from elongation of dietary C14:0, a fatty acid species found in the E. coli diet (Table 
2.1). Since this event must take place in C. elegans, elongation could occur with labeled, 
partially labeled, or unlabeled two-carbon units (Figure 2.5). Palmitate molecules created by 
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elongation of dietary C14:0 would thus yield isotopomers of 270,271, and 272 (if an 
unlabeled C14:0 is elongated) or 284,285, and 286 (if a labeled C14:0 is elongated). The 
accumulation of fatty acid synthesis-independent isotopomers at 282 Daltons was 
insignificant, suggesting that elongation of dietary C12:0 is not a major contributor to C. 
elegans palmitate. To calculate the contribution of C14:0 elongation to the palmitate 
isotopomer distribution, we first quantified the elongation of fully labeled C14:0 to C16:0 
(Equation 6). 
Because dietary palmitate (when isotope impurity peaks are removed) will not contribute 
isotopomers of 284 Daltons, 1284(Abs) can be dropped from this equation. Next, 1285(Elong) 
and 1286(Elong) can be calculated using the relative abundance of [12C_12C], [13C_12C or 12C_ 
13C], and C3C-13C] substrates available for elongation (Equations (7) and (8)). 
(7) 128s(Elong) = 1284(Elong) * (Pi/Pa) 
(8) 1286(Elong) = 1284(Elong) * (PelPa) 
where Pa is the probability of elongating with a [12C_12C] substrate, Pb is the probability of 
elongating with a C3C_12C or 12C_13C] substrate, and Pc is the probability of elongating with a 
[13C_13C] substrate. The same methodology is used to calculate the abundance of 1270, 1271 , 
and 1272 isotopomers due to elongation of unlabeled C14:0. In this case, we use 1272 
abundance (after correction for isotope impurities) to calculate 1271 and 1270 . 
Modeling In(Abs): The Contribution of Dietary Palmitate Absorption 
After taking into account synthesized fatty acids and elongated C14:0, the remainder of 
isotopomer abundance at 1286 is attributable to the direct absorption of fully labeled dietary 
C 16:0 (the probability of obtain ing an isotopomer of 286 Daltons via fatty acid synthesis is 
extremely low, so this term can be excluded from the equation). 
Because maternal inheritance of C16:0 contributes to isotopomers at 1270, we cannot use the 
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same formula to calculate /27o(Abs). However, we can determine the amount of dietary fat at 
270 Daltons using the relative proportion of labeled to unlabeled palmitate available to C. 
e/egans (as determined in our analysis of the bacterial culture described above). 
(10) /270(Abs) = /286(Abs) * CF 
The assumption in this case is that the amount of labeled and unlabeled fatty acids 
absorbed by C. e/egans will be proportional to the relative abundance of labeled and 
unlabeled fatty acids in the bacterial diet. This ratio is determined by analyzing the bacterial 
feeding plate in order to obtain a CF. This CF is obtained by calculating the ratio of 12C_ 
labeled palmitate to 13C-labeled palmitate in the mixed isotope bacterial cultures (see Figure 
2.2). 
Modeling In{Mat): The Contribution of Maternal Fatty Acid 
After accounting for the above three factors, there was a remaining fraction of C16:0 
abundance at 270 Daltons, i.e., fully unlabeled fatty acid. Since our worm growths were 
initiated by placing L 1 larvae on mixed label feeding plates, some of the biomass in these L 1 
larvae may persist into the L4 stage of development. As L 1 larvae biomass is entirely 
derived from unlabeled mothers, maternally contributed fatty acid must be completely 
unlabeled. Therefore, we concluded that the remaining fatty acid at 270 Daltons 
(generally around 5% of total fatty acid) was due to maternal contribution. 
(11) /270(Mat) = /270(Tot) - /270(Abs) - /270(E/ong) - /270(Synth) 
As an independent means of calculating maternal contribution we transferred L 1 larvae, 
which were hatched in the absence of food, to fully labeled 13C bacteria. In this assay, any 
new fatty acids generated during the feeding period will contain 13C isotope and therefore 
possess an MW greater than 270 Daltons. The amount of palmitate remaining at 270 
Daltons was then determined at different time points during development as an indicator of 
maternally contributed fatty acid. Our data confirm that, by the L4 stage of development, the 
maternal contribution of palmitate is generally around 5% of total palmitate (see Figure 2.6). 
This provides a satisfying secondary confirmation of our data analysis. 
26 
Experimental Determination of Acetyl-CoA Isotope Composition 
In principle, the acetyl-CoA isotope composition could be obtained by fitting fatty acid 
synthesis data with a trinomial distribution while allowing the acetyl-CoA isotope composition 
to vary. However, we chose to experimentally assess isotope composition. The E. coli 
(OP50) diet of C. elegans contains insignificant levels of stearate (C18:0); therefore, the 
primary means by which C. elegans obtains C18:0 is by elongation of C16:0 fatty acids. We 
exploited this property to calculate the isotope composition of acetyl-CoA units for each 
experiment (Figure 2.3A and 2.38). If a fully labeled C16:0 is elongated to stearate in C. 
elegans, the MW of stearate will directly reflect the fractions of 12C_12C, 13CYC, and 13C_13C 
acetyl-CoA units. Thus, by quantifying the abundance of C18:0 (/314), C18:0 (/315), and C18:0 
(/316), we can determine the probability of incorporating the different isotopomers of acetyl-
CoA (Equations (12), (13) and (14)). These numbers were calculated after correction for 
isotope impurity. 
(12) Pa = 1314(Tot)/(/314(Tot) + 131S(Tot) + 1316(Tot)) 
(13) Pb = 131S(Tot)/(/314(Tot) + 131s(Tot) + 131dTot)) 
(14) Pc = 1316(Tot)/(/314(Tot) + 131S(Tot) + 1316(Tot)) 
where Pa equals the probability of incorporating a C2C-12C], Pb equals the probability of 
incorporating a [12C_13C or 13C_12C], and Pc equals the probability of incorporating a [13C_13C]. 
The fact that this method for determining acetyl-CoA isotope composition produced models 
that correctly predicted both synthesized and elongated isotopomer distribution in C16:0 
independently confirms our analyses and also argues that the same pool of acetyl-CoA 
is used for elongation and for de novo synthesis. 
Determination of Synthesis Levels for Other Fatty Acids in WT and Mutant Strains 
For the majority of our study, we present data as the fraction of fatty acid that was generated 
through de novo fatty acid synthesis. This number was expressed as the total amount of 
synthesized fatty acid over the total dietary fatty acid taken up or synthesized during the 
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For all fatty acid species, the trinomial distribution described in the previous section was 
used to calculate total fatty acid synthesis. For 18 carbon fatty acids, we used a trinomial 
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Figure 2.1. "Mixed Isotope" Labeling Strategy: C. elegans palmitate (C16:0) can 
be obtained from four distinct sources, and, by feeding worms a 1:1 mixture of 12C_ 
and 13C-enriched bacteria, each of these sources will produce fatty acids with a 
specific MW signature. Because we subsequently analyze fatty acid methyl esters, the 
MW for each C 16:0 isotopomer reflects that of the corresponding methyl ester. Directly 
absorbed C16:0 will either be fully unlabeled (MW = 270) or fully labeled (MW = 286). 
C16:0 produced in C. elegans from elongation of dietary C14:0 will involve fusion of a 
fully unlabeled or fully labeled 14-carbon backbone with labeled, partially labeled, or 
unlabeled acetyl-CoA; consequently, C16:0 created by elongation of C14:0 will 
generate isotopomers ranging from MW = 270-272 and MW = 284-286. Third, fatty 
acids synthesized de novo from dietary metabolites will have a statistical distribution of 
C16:0 isotopomers ranging from MW = 270-286 that depends on the isotope 
composition of the acetyl-CoA pool. Fourth, maternally inherited palmitate will be fully 
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Figure 2.2. Characterization of Palmitate Absorption and Synthesis: (A) Mass 
spectra of C16:0 obtained from bacteria on control feeding plates were averaged (n > 
10) and are displayed here (black bars) as mean fraction of total abundance (± 
standard deviation [SO]). The peak at 270 Oaltons represents C16:0 from bacteria 
grown in fully unlabeled media, and the peak at 286 Oaltons represents C16:0 from 
bacteria grown in 13C-labeled media. The gray bars represent calculation of 
isotopomer peaks resulting from natural 13C isotope in unlabeled media (1 .11 %) and 
12C isotope impurity in the 13C media (1 .5%). Importantly, the absence of detectable 
peaks between 272 and 284 Oaltons shows that no mixing of isotope label occurred on 
the feeding plates . (8) A mass spectrum of C16:0 methyl ester obtained from the total 
lipid of worms grown on a mixed isotope diet from the L 1 to the L4 stage of larval 
development (black). In order to model these data, we accounted for (1) dietary fat 
absorption (red), (2) de novo synthesis (blue), (3) elongation of dietary fat (green), and 
(4) maternal contribution (gray). Our analysis accounted for shoulder peaks due to 
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Figure 2.3. Determining Acetyl-CoA Composition: (A) A mass 
spectrum of stearate (C18:0) obtained from L4 larvae that had been grown 
on mixed label feeding plates from the L 1 stage of development. (B) By 
examining the relative abundance of isotopomer peaks at 314,315, and 
316 Daltons, we calculated the probability of incorporating unlabeled 
(12C-12C), partially labeled (12C-13C), and fully labeled (13C-13C) acetyl-CoA 
isotopomers. Data are the compilation of three experiments and are 
presented as the mean ± SD. 
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C14:0 
284 285 286 
MW of Elongated C16:0 
Figure 2.4. Generation of Palmitate by Elongation of 
Dietary C14:0: Bacterial C14:0 can be elongated in C. 
e/egans by the addition of a two-carbon unit. Thus, the final 
molecular weight of a palmitate generated from a fully 
labeled C14:0 precursor (284,285, or 286 Daltons) will 
depend on the probability of incorporating a 12C_12C, a 
13C_12C, or a 13C_13C unit. 
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Figure 2.5. Secondary Confirmation of Maternal Contribution: A 
population of synchronized L 1 larvae, derived from unlabeled mothers, was 
grown on fully labeled 13C bacteria for 24 or 48 hours. After 48 hours when the 
animals have reached late L4, approximately 5% of the original unlabeled 12C 
fatty acid remained. 
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Figure 2.6. Biosynthetic Origin of C. e/egans Lipids: The most abundant C. 
e/egans fatty acids are shown here along with their biosynthetic origins. The 
proportion of fatty acid derived from synthesis is represented in blue in the pie graphs 
and numerically indicated below. Fatty acid obtained from absorption and/or 
modification of dietary fatty acid is displayed in gray. Data represent the compilation 
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Figure 2.7. Synthesis Contributes Equally to TAG and PL: The percentage of 
fatty acids derived from de novo synthesis in phospholipid (PL), TAG 
(triacylglyceride), and total lipid is shown for WT (N2). Data are presented as the 
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Figure 2.8. Increased Synthesis in daf-2 Animals: We assayed synthesis in 
daf-2 (e1370) mutant animals and found an increase de novo fatty acid synthesis 
represented here by % palmitate synthesis. However, the synthesis increase is 
observed in all fatty acid species measures (see Chapter 3). We also found that 
the synthesis increase was dependent on the presence of the DAF-16 transcription 
factor with no increase in synthesis seen in daf-2(e1370);daf-16(m26) double 
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Figure 2.9. Inhibition of TAG Lipase Activity Results in Decreased Fat Absorption: 
(A) Increasing concentration of the lipase inhibitor, orlistat, results in a dose-dependent 
increase in the ratio of synthesized to absorbed fatty acids. Data shown for palmitate 
synthesis. (8) This skewed ratio can be assigned to decreased fat absorption as the 
TAG:PL ratio decreases indicating reduced fat storage. (C) Changes in the fatty acid 
composition of the treated animals show a relative increase in the abundance of 
synthesized fatty acids (C15iso, C17iso) and a relative decrease in the amount of dietary 
fatty acids (C17D, C18:1n7, C19D). 
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Figure 2.10. Decreased p-oxidation Mutants Show No Change in the Source of Fatty 
Acids: Although our method can not directly detect changes in fat utilization, we used 
nhr-49 (nr2041) (yellow) to demonstrate that the ratios of synthesis and absorbed fatty 
acids are unaffected compared to N2 (black). The data shown is from a minimum of 3 
experiments with SEM. 
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Fatty Acid Species E. coli C. elegans 
C12:0 7.5 ± 0.9 <2% 
C14:0 8.7 ± 0.5 <2% 
C15iso <2% 3.8 ± 0.2 
C16:1n7 3.9±1.1 2.1 ± 0.3 
C16:0 36.6 ± 3.2 3.7 ± 0.5 
C17iso <2% 5.8 ± 0.3 
C17A 16.4 ± 0.6 14.9±0.1 
C18:2n6 <2% 8.1 ± 0.7 
C18:1n9 <2% 4.3 ± 0.5 
C18:1n7 15.6 ± 3.0 19.7 ± 1.6 
C18:0 <2% 2.5 ± 0.9 
C19A 7.5 ± 1.5 6.8 ± 0.5 
C20 PUFAs <2% 25.4 ± 1.1 
Table 2.1. Fatty Acid Composition of E. coli and C. e/egans: Total 
fatty acids from E. coli and C. e/egans were purified, transmethylated, 
and analyzed by GC/MS as described (Watts and Browse, 2002). The 
relative abundance of each fatty acid species is displayed as % of total 
fatty acid. Data are the compilation of 3 experiments and are expressed 
as the mean +/- SEM. The four different C. e/egans C20 polyunsaturated 
fatty acids have been grouped together in this table. 
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CHAPTER III: A 13C Labeling Strategy Reveals the Influence of Insulin Signaling on 
Lipogenesis in C. e/egans 
Sections on DAF-2 pathway are modified from an article published in Cell Metabolism: 
Perez CL and Van Gilst MR. (200S). A 13C isotope labeling strategy reveals the influence 
of insulin signaling on lipogenesis in C. elegans. Cell Metabolism Sep;S(3):266-274. 
Sections on TGF-~ pathway were published in Cell Metabolism: 
Greer ER, Perez CL, Van Gilst MR, Lee BH and Ashrafi K. (200S). Neural and molecular 
dissection of a C. elegans sensory circuit that regulates fat and feeding. Cell Metabolism 
Aug;S(2):11S-131. 
Summary 
Although studies in C. elegans have identified numerous genes involved in fat storage, the 
next step is to determine how these factors actually affect in vivo lipid metabolism. We have 
developed a 13C isotope assay to quantify the contribution of dietary fat absorption and de 
novo synthesis to fat storage and membrane lipid production in C. elegans, establishing the 
means by which worms obtain and process fatty acids. Next, we applied this method to 
characterize how insulin/lGF signaling affects lipid physiology. Several long-lived mutations 
in the insulin receptor gene, daf-2, resulted in significantly higher levels of synthesized fats 
in both triglycerides and phospholipids. This elevation of fat synthesis was completely 
dependent upon the DAF-16/FoxO transcription factor. However, other long-lived alleles of 
daf-2 did not increase fat synthesis, suggesting that site-specific mutations in the insulin 
receptor can differentially influence longevity and metabolism. Importantly, the separation of 
these phenotypes demonstrates that elevated lipid synthesis is not required for the longevity 
of daf-2 mutants. To establish how the lipid metabolism and lifespan are regulated distinctly 
by DAF-2, we measured fatty acid synthesis in a panel of strains with mutations in genes 
encoding components which function downstream of the insulin receptor including the AGE-
1 and SGK-1 kinases. In doing so, we found that lipid synthesis levels were wild-type in 
age-1 mutants but elevated in sgk-1 animals, suggesting a potential mechanism for the 
distinct regulation of the longevity and lipid synthesis phenotypes. Additionally, we were 
able to establish that the impact of insulin signaling on lipogenesis requires, at least partially, 
the function of the TGF-~ transcription regulator, DAF-3, as well as the nuclear hormone 
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receptor, DAF-12. Ultimately, we propose a model which defines DAF-12 as a major 
regulator of lipogenesis, functioning downstream of the insulinllGF and TGF-f3 pathways. 
Introduction 
In addition to its regulation of lifespan and dauer formation, the insulin/lGF signaling 
pathway in C. e/egans also plays a key role in the regulation of fat metabolism (Ashrafi et 
aI., 2003; Hellerer et aI., 2007; Ogg et aI., 1997). Under nutrient rich conditions, the insulin 
receptor, DAF-2, positively regulates the PI3 kinase, AGE-1, which generates pools of PIP3 
signaling molecules. The PIP3 interacts with a suite of kinases including AKT-1 that 
phosphorylates the DAF-16 transcription factor and prevents its translocation into the 
nucleus. When the daf-2 pathway is inhibited, DAF-16 can move into the nucleus and 
orchestrate a transcription program that is important for entry to and survival of the dauer 
state. Dauer, an alternative long-lived larval stage, is associated with increased stress 
resistance and altered metabolism. Additionally, adult animals with altered insulin signaling 
have transcriptional changes that result in lifespan extension and metabolic reprogramming 
similar to the dauer animals (Burnell et aI., 2005; McElwee et aI., 2006; Murphy et aI., 2003). 
Mutations in the insulin-like receptor gene, daf-2, result in an accumulation of lipid, and, like 
many other daf-2 phenotypes, the increased fat storage requires the activity of the FoxO 
homologue, DAF-16 (Ogg et aI., 1997; Yen et aI., 2010). However, it remains unclear what 
types of metabolic changes cause the fat accumulation in the daf-2 animals and what impact 
the altered metabolism has on lifespan. 
The question of how C. e/egans daf-2 regulates lipid metabolism is of particular interest 
given its potential to inform us about how insulin signaling controls longevity. In fact, it has 
been proposed that the changes in fat storage may impact the lifespan of the daf-2 animals. 
Like C. e/egans, knockout of the insulin receptor increases longevity in mice (Holzenberger 
et aI., 2003; Katic et aI., 2007; Kenyon et aI., 1993). The conservation of metabolic 
regulation, however, is less clear, as the effect of insulin signaling on fat storage in 
mammals appears to vary based on tissue and context (Bluher et aI., 2002; Bruning et aI., 
2000; Bruning et aI., 1998); consequently, defining the relationship between insulin receptor 
control of lipid metabolism and longevity, in both C. e/egans and mammals, requires further 
study. 
Although the insulin signaling pathway is important for sensing nutrient availability, it 
does not function in isolation. The TGF-f3 pathway acts synergistically with the daf-2 
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pathway to coordinate a transcriptional response to changing environmental conditions. 
Mutations in the TGF-~ ligand, DAF-7, and its receptor, DAF-1, have also been shown to 
impact fat storage in the nematode through the transcriptional regulator, DAF-3 (Greer et aI., 
2008; Ogg et aI., 1997). Together, DAF-16 and DAF-3 impact the function of the nuclear 
hormone receptor, daf-12, the main component of the steroid hormone pathway. DAF-12 
integrates the inputs from both the insulin and TGF-~ pathways to regulate the decision 
between reproductive growth or dauer diapause. DAF-12 has been found to function 
downstream of the majority of other proteins that regulate the dauer arrest; however, it is 
unclear how these pathways may interact to regulate fat storage. 
In order to better understand the mechanisms by which any fat storage gene impacts 
lipid physiology, tools were needed that allowed for the characterization and quantification of 
fatty acid metabolism in the nematode. To address this need, we have established a 13C 
stable isotope labeling strategy that has allowed us to determine how the nematode 
processes and allocates its diet (Perez et aI., 2008). Here, we have implemented this mixed 
isotope technology to define how the insulin signaling pathway and related pathways 
regulate de novo fatty acid synthesis and fat storage. 
Disruption of Insulin Signaling Leads to Increased De Novo Fatty Acid Synthesis 
In order to determine how the insulin signaling pathway impacts fat storage, we used a 
"mixed isotope" labeling strategy to determine the sources of fat in daf-2 mutants (method 
described in Chapter 2). Worms harboring the commonly studied e1370 allele of daf-2 
contained a >2-fold higher proportion of synthesized fatty acids (Figure 3.1 A). The increase 
in the proportion of synthesized fatty acid is seen in all fatty acid species measured (Figure 
3.18). A higher fraction of synthesized fatty acid might not necessarily reflect an absolute 
increase in de novo synthesis but rather a reduced contribution of dietary fat to the total lipid 
pool. This scenario, however, would result in less total fat storage. Under our conditions, we 
found approximately 80% higher levels oftriglycerides (TAGs) in daf-2(e1370) animals 
demonstrating the daf-2 animals have increased fat synthesis (Figure 3.1 C). These data are 
consistent with previous reports, which implemented different strategies to show a similar 
impact of daf-2(e1370) mutation on fat storage (Ashrafi et aI., 2003; Hellerer et aI., 2007; 
Ogg et aI., 1997). Taken together, we have established a clear role for daf-2 in the 
regulation of de novo fatty acid synthesis. 
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Contribution of Lipid Synthesis to Fat Storage in daf-2 Animals 
Because daf-2(e1370) animals have elevated fat storage, we considered the possibility 
that synthesis was specifically increased in these animals and directly allocated to TAG 
production. To address this question, we analyzed the relative abundance of synthesized 
and dietary fatty acids in TAGs and phospholipids (PLs). We previously found that wild-type 
(WT) animals displayed a similar fraction of synthesized and dietary fatty acids in both lipid 
types ((Perez et aL, 2008) and Chapter 2). In the daf-2(e1370) animals, we found a higher 
proportion of synthesized fatty acids in both TAGs and PLs (Figure 3.1 B). This result 
implies that synthesized and absorbed fatty acids contribute to a common pool that feeds 
both membrane synthesis and fat storage. Thus, in daf-2(e1370) mutants, more 
synthesized fatty acid is available for PL production and for TAG storage. 
We next determined how much of the elevated fat storage observed in daf-2(e 1370) 
animals originated from de novo synthesis. When broken down into synthesized and 
absorbed components, it is clear that there are 3-fold higher levels of synthesized fatty acids 
in daf-2(e 1370) TAGs than in WT TAGs (Figure 3.1 D). This increased supply of synthesized 
fatty acids is sufficient to account for a significant proportion (>60%) of the elevated fat 
storage found in daf-2(e1370) mutants. Additionally, daf-2(e1370) mutants also contain 
higher levels of dietary fatty acids in their TAGs. Much of this increase is likely due to the 
fact that more dietary fatty acid is free for TAG storage because of the larger contribution of 
synthesized fat to PL production. However, because increased fatty acid synthesis often 
inhibits fatty acid j3-oxidation via malonyl-CoA, it is probable that reduced j3-oxidation is also 
a factor contributing to the excess fat stores of daf-2(e 1370) worms. 
Alternative daf-2 Alleles Have Distinct Impacts on Fatty Acid Synthesis 
In addition to the daf-2(e1370) mutation, other long-lived alleles of daf-2 have been 
isolated that contain in site-specific amino acid substitutions in different domains of the 
receptor (Gems et aL, 1998; Patel et aL, 2008). Although these alleles all cause life-span 
extension, they have variable impacts on other aspects of worm physiology, including 
reproduction, pharyngeal pumping, hypoxia resistance and motility (Gems et aL, 1998; 
Mabon et aL, 2009; Patel et aL, 2008). We found that several of these alleles displayed 
dramatically different effects on lipogenesis. Specifically, we found two daf-2 alleles (m577 
and e1368) that did not affect fatty acid synthesis, two alleles (m596 and e1371) that caused 
a moderate increase in synthesis and one allele (m41) that stimulated fatty acid synthesis as 
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strongly as daf-2(e1370) (Figure 3.2A). The level offatty acid synthesis observed in the 
different daf-2 mutants did correlate with the amount of TAG storage in the animals, further 
supporting the conclusion that the elevated fat storage caused by daf-2 mutation is primarily 
due to changes in de novo synthesis (Figure 3.2B). 
In order to establish that the regulation of fatty acid synthesis was independent of 
lifespan, we confirmed that all of these daf-2 alleles led to increased life span under our 
experimental conditions (Figure 3.2C). Furthermore, we did not find any correlation 
between the amount of synthesis increase and the degree of lifespan extension. These 
results demonstrate that increased de novo fatty acid synthesis is not required for lifespan 
extension in daf-2 animals. Notably, the daf-2(m41) animals have the highest levels of 
synthesized fatty acids, but under our conditions, their lifespan extension is the smallest. 
Moreover, because de novo synthesis is responsible for the majority of the increased fat 
storage, we believe that longevity in these animals is also independent of total amount of fat 
stores. 
Insulin Regulation of Fatty Acid Synthesis Depends on DAF-16/FoxO But Is 
Independent of the AGE-1 Kinase 
Because the fat synthesis and lifespan phenotypes of daf-2 are genetically separable, 
we next wanted to define if their regulation required distinct downstream effectors. In order 
to further address the genetic pathways by which insulinllGF signaling impacts fatty acid 
synthesis, we examined age-1 and daf-16 mutants. The impact of insulin signaling on 
longevity is dependent upon both the AGE-1 PI3 kinase and the DAF-16/FoxO transcription 
factor (Kenyon et aI., 1993; Larsen et aI., 1995). When activated, the insulin receptor 
activates AGE-1, which then leads to AKT phosphorylation of DAF-16, and sequestration of 
this FoxO factor from the nucleus (Lee et aI., 2001). Thus, inactivation of age-1 enhances 
longevity by leading to the activation of DAF-16, which we confirmed under our conditions 
(data not shown). Moreover, deletion of daf-16 is sufficient to suppress the longevity of both 
daf-2 and age-1 mutants (Dorman et aI., 1995). We found that the effect of the daf-2(e1370) 
mutation on fatty acid synthesis was completely dependent upon daf-16, as a daf-
2(e1370);daf-16(m26) double mutant displayed WT levels offatty acid synthesis. 
Furthermore, mutation of daf-16(m26) alone resulted in a slight reduction in de novo 
synthesis (Figure 3.2A). In contrast, examination of age-1(hxS46) mutants demonstrated no 
impact of this long-lived allele on fatty acid synthesis (Figure 3.3). We conclude that the C. 
44 
elegans FoxO homolog, DAF-16, can act as a potent stimulator offatty acid synthesis, and 
that, under fed conditions, insulin signaling suppresses de novo synthesis by inhibiting DAF-
16. The fact that the age-1 (hx546) allele did not affect fatty acid synthesis implies again 
that site-specific mutants in the insulin signaling pathway may differentially modulate DAF-
16 activity, such that some mutants may impact DAF-16 so as to affect longevity and fatty 
acid synthesis, and other mutants may activate DAF-16 longevity pathways, but not de novo 
fatty acid synthesis. Taken together, these results imply that daf-16 stimulates fatty acid 
synthesis, and that activation of the insulin signaling pathway represses de novo synthesis, 
at least in part, by inhibition of daf-16. 
The Role of SGK-1 In Regulating Synthesis 
In order to understand how the DAF-2 receptor regulates synthesis, we tested the 
requirement of the components of the insulin signaling pathway. When activated, DAF-2 
positively regulates the AGE-1 kinase as described above. The phosphatidylinositol kinase 
catalyzes the phosphorylation of PIP2 to PIP3, which in turn activates a number of 
downstream kinases including the AKT kinase family proteins, AKT-1 and AKT-2, and the 
serum- and glucocorticoid-inducible kinase homolog (SGK-1) proteins. These kinases 
phosphorylate the DAF-16 transcription factor, which blocks its ability to move into the 
nucleus where it can activate its target genes. We quantified the rates of fatty acid 
synthesis in mutants of these kinases and found no role for AKT-1 or AKT-2 in regulating 
fatty acid synthesis. However, the sgk-1(ok538) animals had a Significant increase in the 
relative abundance of synthesized fatty acids (Figure 3.3A). Therefore, we wanted to test 
whether SGK-1 regulation of de novo fatty acid synthesis was dependent on DAF-16. To do 
this, we constructed a sgk-1(ok538);daf-16(m26) double mutant and found that these 
animals have wild-type synthesis (Figure 3.3A). In vitro, it has been determined that SGK-1 
is dependent on the function of a 3-phosphoinosite-dependent kinase called PDK-1 
(Hertweck et aI., 2004). A gain of function mutant of pdk-1 (mg142) has been described, and 
we have preliminary evidence that this activating mutation can fully rescue the high 
synthesis of the daf-2(e1370) mutant. Taken together, we believe that this provides 
evidence that lipogenesis and lifespan are regulated by distinct signaling pathways with 
lipogenesis being regulated by the SGK-1 kinase. However, further study is required to 
elucidate the interactions between the insulin signaling components and to identify unknown 
players (Figure 3.4). 
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We thought that other pathways that impact the OAF-16 transcription factor might playa 
role in regulation of fatty acid synthesis; however, we did not find any change in fatty acid 
synthesis in mutants of the JNK (c-Jun !i-terminal Kinase) or EAK (~nhancer of AKT-1) 
pathways (Table 3.1). Therefore, we predict that an unidentified pathway may converge on 
the SGK-1 kinase and OAF-16 transcription factor to regulate fatty acid synthesis. In a 
screen of known fat storage mutants, we identified a Type" Pl3-Kinase that may playa role 
in regulating synthesis independent of age-1; however, we have not yet confirmed the 
involvement of this kinase in the insulin signaling pathway (described in Appendix I). 
DAF-12 as A Master Regulator of Fat Synthesis 
In unfavorable environments, the insulin signaling pathway functions through daf-16 to 
downregulate the expression of OAF-9, a cytochrome P450 that functions in the 
biosynthesis of the OAF-12 ligand. daf-12 encodes a nuclear receptor that regulates the 
dauer diapause and lifespan (Rottiers et aI., 2006). To test whether fat metabolism 
regulation was mediated by daf-12, we assayed synthesis in several daf-12 mutants. We 
found that in daf-12(rh273) , a dauer-constitutive allele, there is a significant increase in fat 
synthesis (Figure 3.5A). Another dauer-constitutive allele, rh274, results in a much less 
dramatic increase in fat synthesis. Additionally, in daf-12(m20) and daf-12(rh61rh412) 
animals which are dauer-defective, there was no increase in synthesis (Figure 3.5A). 
Next, we tested whether daf-12 activity was essential for the synthesis increase seen in 
daf-2(e1370) animals. In daf-2(e1370);daf-12(m20) animals, the increase in synthesis was 
partially reduced indicating a role for OAF-12 in the regulation of synthesis (Figure 3.5B). 
This result is particularly intriguing as daf-12(m20) enhances the longevity of a daf-2(e1370) 
animal (Patel et aI., 2008). Taken together, this data suggested a role for daf-12 in the 
regulation of fatty acid synthesis; however, more work needs to be done to fully establish the 
impact of OAF-12 on lipogenesis. 
The TGF-~ Pathway Regulates Lipogenesis As We" 
The TGF-f3 pathway is an important nutrient sensing pathway that also regulates lifespan 
and dauer development that acts synergistically with the insulin-like signaling pathway. The 
TGF-f3 receptor, OAF-1, is activated by its ligand, OAF-?, and results in the inhibition of the 
transcriptional regulator OAF-3. Because the TGF-f3 pathway also converges on daf-12, we 
measured fatty acid synthesis in mutants of the TGF-f3 ligand, daf-7(e1372) and its receptor, 
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daf-1(m40). We found an -3-fold increase in de novo fatty acid synthesis in these animals. 
Additionally, this increase was dependent on the downstream effector, daf-3, as abundance 
of synthesized fatty acids is wild-type in daf-1(m40);daf3(mgOf90) animals (published in 
(Greer et aI., 2008); Figure 3.SC). Not only does this data support the role of daf-12 in 
regulating synthesis, but this increase also suggests that increased lipogenesis may be a 
fundamental component that allow dauer larvae survival. 
Discussion 
There has been considerable interest in the C. e/egans insulin receptor due to its 
influence on longevity, stress resistance, and lipid storage (Kenyon et aI., 1993; McElwee et 
aI., 2006; Wolkow et aI., 2000). The commonly studied daf-2(e1370) allele blocks insulin 
signaling, extends life span, and leads to elevated fat accumulation. We found that daf-
2(e1370) animals have more than double the amount of synthesized fatty acids in TAG and 
PL, implying that de novo synthesis is the predominant mechanism by which the insulin 
signaling pathway affects fat storage in C. e/egans. This conclusion is further supported by a 
positive correlation between the fatty acid synthesis levels of different daf-2 mutants and 
their total fat storage. 
Our results with alternative daf-2 alleles also show that the impacts of the insulin 
receptor on lifespan and lipogenesis are genetically separable. Thus, the enhanced 
longevity of daf-2 mutants does not require increased lipid synthesis. The structural position 
of the daf-2 alleles studied here does not provide a clear explanation for their distinct effects 
on longevity and lipid synthesis (Figure 3.6). The two alleles with the strongest 
enhancement of de novo synthesis are m41 and e1370. The e1370 mutation localizes near 
the active site of the kinase domain, where it could potentially interfere with downstream 
signaling. The m41 allele localizes to the L 1 domain, which is responsible for ligand 
interaction; however, m41 does not alter an amino acid predicted to make direct contact with 
the insulin ligand. The m577 and e1371 mutations both localize to the Fnl1l2 domain, but 
only one of these alleles affects de novo synthesis. Furthermore, m596 and e 1368 localize 
to the L2 domain but also impact lipid synthesis differently. Both the Fnl1l2 domain and L2 
domain reside in the extracellular portion of the insulin receptor and do not directly 
participate in ligand binding or kinase interaction. Thus, these daf-2 mutations may directly 
disrupt interaction with an undefined factor or may indirectly alter ligand binding or kinase 
activation by differentially perturbing allosteric changes. Alternatively, daf-2 alleles may 
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have distinct impacts on protein stability, thus varying the strength of the insulin response. 
Further genetic and structural investigation will be necessary to establish how these simple 
site-specific mutations distinctly affect DAF-16/FoxO activity, longevity, and lipogenesis. In 
any event, the fact that we were able to identify insulin receptor mutants that specifically 
impacted life span, but not metabolism, suggests that targeted mutations in the insulin 
receptor may be able to manipulate distinct physiological outcomes; such a finding warrants 
further investigations in C. e/egans and mammalian models. 
The fact that daf-16 is required for both longevity and elevated fat synthesis suggests 
that daf-16 might respond differently to distinct daf-2 mutations, such that some mutations 
activate its capacity to promote longevity but not de novo lipogenesis (Figure 3.6A). This 
could occur because differential modification of daf-16 is required for its impact on 
lipogenesis, because of tissue-specific differences in the signaling mechanism, or because 
daf-16 control of lipogenesis may be more sensitive to signaling dosage. Alternatively, the 
effect of the daf-2(e1370) mutation on lipogenesis may involve an additional factor that 
functions together with daf-16 to stimulate fatty acid synthesis. In this case, some daf-2 
alleles may not influence this additional factor. We found that the age-1 (hx546) allele, which 
also results in daf-16-dependent lifespan extension, did not impact de novo synthesis. 
These findings demonstrate that site-specific mutations in the insulin receptor or 
downstream components are able to selectively mediate the longevity enhancing effects of 
DAF-16/FoxO, without impacting DAF-16/FoxO control of de novo fatty acid synthesis. 
There are several explanations for these observations. First, age-1 and daf-2 alleles may 
be hypomorphic, in that their function is reduced enough to allow DAF-16/FoxO to instill 
longevity programs, but not reduced enough to enable DAF-16/FoxO to stimulate de novo 
lipogenesis. Second, these mutant alleles may lead to loss of function in tissues that 
modulate aging, but not tissues that control fatty acid synthesis. This second model may be 
supported by the findings of Wolkow et aI., which showed that tissue specific expression of 
daf-2 in muscle could rescue the fat storage phenotype of the daf-2(e 1370) worms, but not 
the enhanced longevity (Wolkow et aI., 2000). Finally, insulin control of fatty acid synthesis 
may proceed through an alternative pathway, which does not involve the age-1 kinase. In 
this scenario, the specific mutant alleles of daf-2 that do not affect fatty acid synthesis may 
be selectively compromised in their ability to activate the AGE-1 pathway that controls 
aging, but not the pathway that regulates fatty acid synthesis. In order to begin to address 
these models, we analyzed the impact of other insulin related pathways on lipogenesis. We 
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did not find a role for either the JNK or EAK pathway in regulating synthesis suggesting that 
an uncharacterized pathway downstream of the DAF-2 receptor may regulate the lipogenic 
phenotype. This pathway may involve the function of SGK-1 as we did find increased fat 
synthesis in the sgk-1 mutant, which implicates this alternative kinase in fat regulation. 
However, it is not yet clear how SGK-1 is differentially regulated in this context. Additionally, 
further genetic analysis will be required to fully distinguish between these models; however, 
we predict that synthesis regulation will be modulated by a distinct pathway and are 
currently screening for such a pathway (Figure 3.4). 
The mixed isotope labeling strategy also allowed us to define the regulation of de novo 
fatty acid synthesis downstream of daf-16. Our studies established a role for DAF-12 and 
DAF-3 in regulating lipogenesis in C. elegans (Figure 3.7). This function is of particular 
interest as DAF-12 has homology to mammalian nuclear hormone receptors which function 
in the regulation of lipid metabolism, the liver X receptor alpha and beta (LXRA and LXRB) 
(Mooijaart et aI., 2005). This steroid signaling pathway has also been linked to longevity 
and to reproduction in C. elegans, making future studies in the nematode particularly 
interesting (further discussed in Chapter IV). It is interesting to note that all of the genes that 
regulate fatty acid synthesis also playa role in the formation of the dauer larva. The 
connection of lipogenesis to the dauer state may suggest a requirement of synthesis for 
dauer initiation and survival. 
Experimental Procedures 
Strains 
Strains were maintained at 20°C on HG plates seeded with E. coli (OP50). The following 
alleles were provided by the CGC: wild-type N2 Bristol, DR1567: daf-2 (mS77), CB1370: 
daf-2 (e1370), DR1564: daf-2(m41), DR1572: daf-2(e1368), DR1565: daf-2(mS96), 
DR1568: daf-2 (e1371), DR1309: daf-2(e1370);daf-16(m26), DR26: daf-16(m26), CF1038: 
daf-16(mu86), TJ1052: age-1 (hxS46), HT941:jnk-1(+); rol-6(su1066), HT942:jnk-1(+); rol-
6(su1066), HE1006: rol-6(su1006), M87: daf-12(rh273), DR20: daf-12(m20), CB1372: daf-
7(e1372), DR40: daf-1(m40), GR1310: akt-1(mg144), JT573: akt-1(saS73), K0154: akt-
2(tm812) and K01120: sgk-1(okS38). EAK mutants, B06: eak-7(mg338) and B08: hsd-
1(mg34S), were provide by Patrick Hu from University of Michigan. DR1547: daf-
2(mS77);daf-12(m20) and DR1296: daf-2(e1370);daf-12(m20) were provided by David 
Gems. The daf-1(m40);daf-3(mgOf90) strain was constructed and provided by Kaveh 
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Ashrafi. The sgk-1(ok538);daf-16(mu86) was constructed by standard mating and 
genotyping procedures. The mu86 allele was chosen because it is a deletion allele that can 
easily be distinguished by PCR amplification and impact on synthesis is the same. 
Mixed Isotope Method 
The isotope labeling strategy. lipid extraction procedures and GC/MS detection were 
implemented as described in the experimental procedure section of Chapter 2. Briefly, 
separate cultures of bacteria are grown in 12C LB media and 13C Isogro media. Bacteria is 
harvested, weighed, and mixed in a 1:1 ratio on agarose plates. 30,000 L 1 animals are 
plated on the mixed isotope plates and grown till L4 at 20°C, then collected and frozen. 
Lipids are then are extracted and analyzed via GC/MS. 
Lifespan Analysis 
Previous studies had reported the lifespan of the different daf-2 alleles at 18°C and 22.5°C 
(Gems et aI., 1998). Our fatty acid synthesis experiments were all carried out at 20°C. 
Therefore, because these daf-2 alleles are temperature sensitive, we determined the 
lifespan of each daf-2 mutant included in our study at 20°C. Lifespan assays were carried 
out as previously described (Hsin et aI., 1999). Bagged and lost animals were excluded 
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Figure 3.1. Regulation of Fatty Acid Synthesis and TAG Storage by daf-2: (A) 
Isotopomers exclusively associated with de novo synthesis (MW 274- 280) are 
increased in palmitate isolated from the total lipid of the daf-2(e1370) animals (red), as 
compared to WT animals (gray). Data are the mean of five experiments ± SO . (8) The 
percentage of fatty acids derived from de novo synthesis in phospholipid (PL), TAG 
(triacylglyceride), and total lipid is shown for WT (N2) and daf-2(e1370). Data are 
presented as the mean of three experiments ± SEM. (C) The total amount of TAG in 
N2 and daf-2(e1370) mutants. Data are displayed as mean TAG:PL ratio ± SEM. (0) 
For each fatty acid , we used total TAG measurements along with fatty acid synthesis 
data to estimate the relative abundance of dietary (Abs) and synthesized fatty acid in 
the TAG of N2 and daf-2(e1370) animals. 
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Figure 3.2. Alternative Alleles of daf-2 Have Different Impacts on Lipogenesis: 
(A) The relative amount of de novo synthesis in various daf-2 and daf-16 mutants. 
Data presented here are for palmitate; however a similar pattern was observed for 
most other fatty acid species (data not shown). Data represent the mean of at least 
five experiments ± SEM. (8) TAG measurements in WT and daf-2 mutants. Numbers 
shown represent the mean of at least five experiments ± SEM. (C) Lifespan analysis 
was performed for all mutant strains at 20°C. The mean lifespans +/- SE are: N2: 
16.7±0.49; daf-2(e1368): 28.4±O.6; daf-2(e1370): 34.0±1.3; daf-2(e1371): 26.5±1.2; 
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Figure 3.3. SGK·1 Regulates Fatty Acid Synthesis: (A) We quantified de novo 
fatty acid synthesis in mutants of other components of the insulin signaling pathway 
and found that genes that regulate lifespan (age-1, akt-1 , and akt-2) did not alter the 
levels of lipogenesis. However, sgk-1 animals had a 70% increase in the levels of 
synthesis. This increase was dependent on daf-16 as determined by the WT synthesis 
levels found in sgk-1 ;daf-16 double mutant. 
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Gene C16:0 SYnthesis 
ink-1 (lpln1) 5.0 ± 0.5 
jnk-1 (lpln2) 6.9 ± 0.5 
hsd-1 (mg345) 4.3 ± 0.4 
eak-7 (mg338) 5.7 ± 0.4 
N2 5.5 ± 1.0 
Table 3.1. Palmitate Syntheis in JNK and EAK Pathway Mutants: JNK-1 
overexpression lines (lpln1 and Ipln2) and mutants in components of the EAK pathway 
(hsd-1 and eak-7) had wild-type levels of C16:0 synthesis. Data from a minimum of 3 
experiments with SEM shown. 
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Figure 3.4. Model for the Distinct Regulation of Lifespan and Lipogenesis by 
DAF-2: Mutants in the insulin pathway that result in high synthesis (blue), wild-type 
synthesis (grey) and reduced synthesis (green) are shown with unidentified 
relationships shown with broken lines. Further genetic epistasis analysis will be 
necessary to complete the pathways that impact lipogenesis. 
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Figure 3.5. Regulation of Fatty Acid Synthesis By DAF-12 and DAF-3: (A) 
Palmitate synthesis was quantified in a series of daf-12 alleles with dauer-defective 
alleles shown in grey and dauer-constitutive alleles shown in yellow. (8) Next, we 
identified an interaction between the DAF-2 and DAF-12 pathways by measuring 
synthesis in daf-2;daf-12 double mutants. (C) Finally, we found synthesis is also 
regulated by the TGF-13 pathway. All synthesis measurements are from a minimum of 
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Figure 3.6. Insulin Signaling Mutants Differentially Impact Lipogenesis: (A) Our 
findings demonstrate that insulin signaling suppresses de novo synthesis by inhibiting 
the lipogenic function of DAF-16/FoxO. Some alleles of daf-2 increase de novo 
lipogenesis and enhance longevity, whereas other daf-2 alleles lead to daf-16-
dependent longevity but do not cause stimulation of de novo synthesis. Thus, site-
specific mutations in the insulin receptor gene can differentially affect longevity and 
lipogenesis, implying that the downstream mechanisms utilized to generate these 
physiological outcomes are, at least partially, distinct. (8) The predicted locations of 
the daf-2 alleles used in this study are displayed on a structural diagram of the insulin 
receptor. The cartoon is based on alignment of the DAF-2 protein with the human 
insulin receptor (Patel et aI., 2008). 
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Insulin/lGF-1 Signaling 
Fatty Acid Synthesis 
Figure 3.7. Model for Integration of Nutrient Sensing Pathways and Lipogenesis: 
In favorable environments with plentiful food, both insulin and TGF-13 signaling will be 
on resulting in the suppression of the downstream transcription factors (DAF-16 and 
DAF-3, respectively). This will result in the promotion of reproductive development by 
the DAF-12 nuclear receptor and low levels on synthesis. However, in an unfavorable 
environment, both signaling pathways will be off, resulting in the promotion of 
increased de novo synthesis by DAF-12. 
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CHAPTER IV: The Impact of de novo Fatty Acid Synthesis on Reproduction and 
Longevity 
Summary 
An animal must be able to process its diet and allocate the resources appropriately to a 
number of distinct physiological fates. The partitioning of dietary molecules must be 
modified as the animal encounters different environmental conditions and metabolic needs, 
and the ability of an organism to utilize its resources efficiently may have dramatic impacts 
on growth, homeostasis, reproduction and aging. Because reproduction requires a large 
amount of resources, a metabolic shift may be an important component for successful 
progeny production and continued somatic maintenance. We have used a "mixed isotope" 
labeling strategy in C. e/egans to define the changes in fat metabolism in reproductive adult 
animals. This isotope analysis has revealed that, at the onset of adulthood, the relative 
amount of de novo fatty acid synthesis almost doubles indicating a significant change in how 
the diet is processed. Fatty acid quantification also established that there is an increase in 
the abundance of monomethyl branched chain fatty acids (mmBCFAs), fat species essential 
for development, at this time as well. Further analysis has demonstrated that this increase 
in synthesis correlates with the reproductive period but is not involved in germ cell 
production or in germline migration. Direct analysis of the embryos themselves found that 
there is an enrichment of synthesized fatty acids in the triglycerides of the embryo indicating 
that de novo lipogenesis at this time may be important for supplying fatty acids to the 
developing oocytes. Because of the increase in de novo fatty acid synthesis in adults, we 
also examined the requirement of the fatty acid synthase (fasn-1) gene in survival. In doing 
so, we found that fasn-1 RNAi results in a reduction in the adult lifespan indicating an 
important function for lipogenesis in the adult. Taken together, we have established a model 
that the lipogenic transition in reproductive adults is important for: (1) the generation of 
mmBCFAs for embryos, (2) provision offatty acids for TAG synthesis in the germline, and 
(3) somatic maintenance under the increased demands of reproduction. 
Introduction 
Reproduction is an energetically costly process, and, in fact, in C. e/egans, there are 
many more mitotic divisions required for the production of a full brood than are needed for 
the growth and development to adult. The large amount of resources needed to produce 
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progeny may limit the availability of ATP and substrates for other physiological processes. 
In fact, there have been many studies that have suggested a tradeoff between reproduction 
and lifespan. Conditions that increase lifespan like dietary restriction, which has been found 
to extend lifespan in both nematodes and mammals, often result in a decline in fecundity 
(Flatt,2009). Additionally, many mutations that result in lifespan extension are also 
associated with a reduction in reproduction. For example, strong mutations in the 
insulin/lGF-1 pathway result in a dramatic lifespan extension, but these animals also have a 
delayed onset of reproduction and reduced brood size (Kenyon, 2010). However, the 
extension of lifespan is not always at the cost of fecundity, as weaker mutations in the same 
insulin/lGF-1 pathway also result in longevity phenotypes without any detriment in brood 
production (Kenyon, 2010). In addition to the correlative relationships between lifespan and 
fecundity, studies have also found that the reproductive tissues themselves can impact the 
lifespan of the organism. In C. e/egans, it has been established that the germline precursor 
cells and the somatic gonad can playa substantial role in the regulation of lifespan (Arantes-
Oliveira et aI., 2002; Yamawaki et aI., 2010). The relationship between lifespan and 
reproduction may be explained by differences in the ability to allocate resources to the 
proper fates. 
In fact, there have been a number of indications that the germline can impact lifespan by 
driving changes in fat metabolism. First, the nuclear hormone receptor, DAF-12, and the 
FoxO transcription factor, DAF-16, are required for the longevity associated with the loss of 
germ cells (Yamawaki et aI., 2010). Because both of these signaling pathways have been 
implicated as key regulators of fat metabolism, it is possible that the lifespan extension may 
be due to their ability to partition nutrients to the germline. We have characterized both 
DAF-12 and DAF-16 as regulators of de novo fatty acid synthesis in larval animals; 
however, the role of these factors in regulating lipogenesis during reproduction has not been 
investigated (Chapter III and (Perez et aI., 2008)). Additionally, recent studies have found 
that a lipase is genetically linked to reproduction and aging, and it has been proposed that 
this lipase affects lifespan through lipid hydrolysis and fat mobilization (Wang et aI., 2008). 
However, these connections have not been explored with direct biochemical approaches. A 
stable isotope approach in combination with lipid biochemistry would allow the direct 
monitoring of how these fats are being processed and mobilized for reproduction. A further 
understanding of how fat metabolism is connected to reproduction may provide key insights 
into the regulation of aging. 
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In recent years, a relationship between reproduction, metabolism and aging has 
started to emerge; however, a clear understanding of these relationships has not been 
established. The remaining questions have been left unanswered, at least in part, due to 
the difficulty in directly studying the impacts of metabolism. In particular, the regulation of fat 
storage by reproduction has been difficult to thoroughly understand, as the tools for 
monitoring fat storage have yielded varied results. For example, utilization of lipophilic dyes 
like Nile Red and Sudan Black have found decreased fat storage in germline minus animals 
(Wang et aI., 2008). However, biochemical methods for measuring fat storage have found 
the same animals have elevated triglyceride to phospholipid ratios indicating higher amounts 
of fat stores (O'Rourke et aI., 2009). We have established a "mixed isotope" labeling 
strategy that allows us to determine how dietary nutrients are utilized. The advantage of this 
mixed isotope labeling strategy is that we can directly monitor changes in fatty acid 
metabolism, and, here, we have implemented this labeling scheme to quantify differences in 
the fatty acid metabolism of reproductive animals. 
Lipogenic Shift Between Larval and Adult Animals 
In previous work, we developed stable isotope labeling technology in C. e/egans that 
allows us to trace dietary carbons into the fats of the animal. This strategy allows us to 
accurately quantify the relative abundance of de novo synthesized fatty acids and fatty acids 
absorbed directly from the diet (Perez et aI., 2008). We have used this mixed isotope 
strategy to characterize how L4 nematodes process their diet. However, because these 
developing animals may allocate nutrients differently than adults, we next wanted to assess 
how reproductively competent adult animals utilize the same dietary resources. In order to 
monitor the allocation of dietary nutrients in adults, we utilized the same stable isotope 
labeling approach to quantify the flux of dietary carbon into the lipids of the adult nematodes. 
In doing so, we found that there is a dramatic shift in the way the animals process their diet 
between larvae and adult. In L4 animals, the majority of palmitate (C16:0) is obtained 
directly from the diet with only 7% coming from de novo fatty acid synthesis. However, just 
24 hours later, there is an 81 % increase in the relative amount of palmitate derived from 
synthesis (Figure 4.1). 
One of the key advantages of this mixed labeling strategy is that we can examine the 
contribution of fatty acid synthesis to other fatty acid species. This ability allows us to 
ascertain whether de novo synthesis is contributing specifically to the formation of any 
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particular fatty acid species. Additionally, because elongation and desaturation of palmitate 
requires additional enzymes, we can detect perturbations in these fatty acid modification 
pathways concurrently. We found increased fatty acid synthesis in all other fatty acid 
species measured including stearate (C18:0) and linoleate (C18:2n6) with an 82% and 98% 
increase in the relative contribution of synthesis, respectively (Figure 4.1). The elevated 
synthesis observed in these fatty acid species may demonstrate a coordinated upregulation 
in fatty acid synthesis enzymes and the fatty acid elongation and desaturation pathways. 
However, when we quantified fatty acid synthesis in the vaccenic (C 18: 1 n7) pathway, we did 
not see an increase in synthesized fatty acids, indicating that there is not a global 
upregulation of synthesis activity. These results suggest a regulated increase in fatty acid 
synthesis and processing in adult animals that has not been recognized as of yet. 
Given the timing of the increase in fatty acid synthesis, we wanted to test whether the 
production of embryos drives the lipogenic increase. Therefore, we tested whether the 
elevated synthesis is seen only at the onset of adulthood or whether it is a persistent feature 
of adult metabolism. To do this, we grew wild-type N2 animals on mixed isotope growth 
plates as far as possible (until day 3 of adulthood when the number of progeny make 
interpretation difficult), collecting a population of animals on each day of adulthood. We 
found that the relative contribution of de novo fatty acid synthesis increases in the first three 
days of adulthood (Figure 4.2). Although the largest change in palmitate synthesis is seen 
between L4 and adult (1.8-fold), the relative amount of palmitate synthesis continues to rise 
between day 1 and day 2 of adulthood (1.6-fold). Then, the rates begin to level out with the 
change between day 2 and day 3 being only 1.1-fold. Together, the total increase in fatty 
acid synthesis is quite dramatic over the first days of adulthood with about a 3-fold increase 
in the amount of synthesis in C16:0, C18:0, and C18:2n6. In fact, the rates of de novo 
synthesis are among the highest that have been observed in the nematode thus far. 
Moreover, the rates of fatty acid synthesis are continuing to increase when the majority of 
progeny are produced, suggesting a potential connection between fatty acid synthesis and 
reproduction. 
Rates of Fatty Acid Synthesis Over the Reproductive Period 
Because the wild-type N2 adults are continuously laying fertilized eggs, we wanted to 
eliminate any possible impact of the hatched progeny's metabolism. Therefore, we utilized 
the fem-1;fer-15 temperature sensitive sterile strain which has defects in both 
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masculinization of the germline and spermiogenesis. The fem-1;fer-15 animals are 
therefore sterile at 25°C but have otherwise normal female germline and produce 
unfertilized embryos. The increase in fatty acid synthesis is intact in the fem-1 ;fer-15 
animals suggesting that the lipogenic shift is a product of the metabolism of the adult 
animals and not the developing F1 larvae that have hatched on the plates (Figure 4.2). In 
fact, the contamination of progeny at day 3 adult in the N2 collections may have artificially 
reduced the rates of synthesis, as we see a 1.4-fold increase in the fem-1;fer-15 animals 
(opposed to the 1.1-fold change seen in N2s). 
We next wanted to test whether synthesis rates returned to larval levels after progeny 
production stopped. The implementation of the fem-1;fer-15 strain allowed us to extend out 
analysis until the cessation of egg-laying. In order to quantify synthesis in the adult animals, 
we plated L 1 animals on mixed growth plates and collected the isotope-labeled animals as 
far out as day 9. The relative abundance of synthesized fatty acids continues to increase 
during the time period when the animals are actively producing eggs (until about day 3 of 
adulthood at 25°C). After the fertile period (day 4), there is no significant increase in the 
amount of de novo synthesis after day 3 as seen with palmitate (C16:0) and linoleate 
(C18:2n6); however, the synthesis rates do not return to their baseline larval levels (Figure 
4.3). We do see a reduction in the relative abundance of synthesized C16:0 and C18:2n6 at 
day 9 to 23% and 30%, respectively; moreover, these numbers are likely overestimates as 
the feeding rates are also reduced in day 10 animals which would result in a relative 
increase in synthesis rates due to decreased fat absorption. Nevertheless, this evidence 
suggests that the lipogenic transition seen at adulthood is tightly connected to reproduction. 
Fatty Acid Synthesis Is Not Required for the Production of Germ Cells 
There are many aspects of reproduction that might require and/or benefit from a 
lipogenic metabolism including germ cell formation and development, provision of sufficient 
fats to the germline or adequate supplies of particular synthesized fatty acid species. It has 
been established that the main fatty acid synthesis enzymes, fatty acid synthase (fasn-1) 
and acetyl-CoA carboxylase (pod-2) are essential for embryonic viability. When either 
enzyme is depleted by RNAi in the mother, this deficiency leads to embryonic lethality due 
to a failure in proper polarization of the embryo (Rappleye et aI., 2003). Additionally, RNAi 
of fasn-1 at L 1 leads to permanent L 1 arrest and lethality establishing a role for fasn-1 in 
larval development as well as in embryonic development. However, there has not been an 
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established role for fasn-1 in a reproductive adult. Because of the timing of the lipogenic 
transition, we theorized that de novo synthesis might be important for the formation of germ 
cells. We tested the impact of de novo fatty acid synthesis on germ cell development by 
treating larval animals with fasn-1 RNAi. This treatment was initiated after 24 hours of 
development on control bacteria (L4440) to bypass the larval arrest phenotype. To 
determine if a full complement of germ cells developed, the number of produced embryos 
was then counted. We found that, although none of the embryos developed as expected, 
there was no deficiency in the number of embryos produced, demonstrating that fat 
synthesis is not required for germ cell production (Figure 4.4). 
Additionally, we looked at germline progression by DIC microscopy and did not see any 
defect in germline migration in animals treated with fasn-1 RNAi using the same RNAi 
feeding scheme described above (Figure 4.5). Because of the necessity to bypass the 
larval arrest, we could not test ifthere is a requirement for fasn-1 earlier in germline 
development. However, because germ cell formation continues into early adult stages, we 
believe this is evidence that fasn-1 does not playa role in germline migration and germ cell 
formation. 
The Lipogenic Transition Contributes to the Production of mmBCFAs 
We next explored whether fatty acid synthesis was elevated to produced sufficient 
quantities of a particular fatty acids species. To determine if the abundance of these fatty 
acids increases during this period, we quantified the relative abundance offatty acids in L4 
and day 1 adults. Between L4 and adult, we did not see a significant enrichment in de novo 
synthesis in any particular fatty acid species (Figure 4.1). Also, there is little change in the 
relative levels of straight chain fatty acids between L4 and adult (Figure 4.6A). However, 
there are several types of fatty acids where synthesis rates can not be ascertained directly 
by our detection methods or labeling strategy including the C20 polyunsaturated fatty acids 
(PUFAs) and monomethyl branched chain fats (mmBCFAs). We were particularly interested 
in the mmBCFAs, C151S0 and C171S0, as they have been found to be essential for larval 
development (Kniazeva et aI., 2004). Because the mmBCFAs are not found in the diet and 
are fully de novo synthesized, we hypothesized that the increase in fatty acid synthesis may 
function to provide the progeny with appropriate levels of mmBCFAs. The mmBCFAs are 
synthesized by the same fatty acid synthase enzyme that produces straight chain fatty 
acids, but their synthesis is initiated by a branched chain primer instead of malonyl-CoA. We 
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did find an increase in the relative abundance of C171S0 between L4 and adults animals 
(Figure 4.6A). When we analyzed the fatty acid composition of the embryos themselves, we 
found a slight but significant enrichment in the mmBCFAs in both TAG and PL (Figure 4.6B 
and 4.6C). Interestingly, we also detected a decrease in the relative abundance of C16:0 
(Figure 4.6A). Because the precursor for mmBCFAs is formed by the same fatty acid 
synthase enzyme that produces C16:0, we believe that this may indicate a bias in the 
elongation of branched chain primers which generate mmBCFAs by FASN-1. We are 
currently testing the importance of mmBCFA synthesis by quantifying the mmBCFA 
abundance in fasn-1 RNAi embryos. 
The C131S0 generated by FASN-1 requires the activity of elongases (eI0-5 and eI0-6) 
to produce full length C151S0 and C171S0 fatty acids. When adult animals are treated with 
e10-5 RNAi, there is no larval arrest in their progeny, and, in fact, these F1 animals continue 
to develop into adults which allows us to learn more about the function of mmBCFAs in 
germline formation (Kniazeva et ai., 2004). Eventually, after the fertilization of very few 
oocytes (-1-10), there is a defect in oogenesis and a progressive degeneration of the gonad 
(Kniazeva et ai., 2004). Because we do not see defective oogenesis in adult animals 
treated with fasn-1 RNAi (Figure 4.4), we believe that mmBCFA formation is not the primary 
driver of lipogenesis during reproduction. However, we do see deterioration of the adult 
germline in fasn-1 treated animals in preliminary experiments suggesting that mmBCFA 
deficiency may contribute to the overall status of the gonad (data not shown). 
Synthesized Fatty Acids Are Distributed Equally to TAG and PL Populations 
Because the production of oocytes requires formation of new membranes, we 
hypothesized that the increase in fatty acid synthesis may be important for the formation of 
adequate PL pools. Alternatively, it is also possible that de novo synthesized fatty acids 
would be funneled into TAG synthesis to provide the embryo with sufficient long term energy 
reserves. To assay the contribution of fatty acid synthesis to different lipid classes, we grew 
animals on mixed isotope labeled food until L4 and adult and then purified neutral lipids 
(TAG) and phospholipid (PL) populations. This analysis clearly demonstrated that the 
relative contribution of synthesis is equal for each fatty acid species regardless of whether 
the fatty acid was associated with TAG or PL (Figure 4.7). For example, the amount of 
synthesized palmitate is about 7% in both TAG and PL at L4, and there is an equivalent 
increase in both lipid classes with synthesis contributing to about 13% of palmitate in TAG 
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and PL of adults. This data suggest that the increase in de novo synthesis contributes to 
the overall pool of fatty acids and is not biased to any particular lipid species. 
A Functional Germline Is Not Required for Upregulation of Synthesis 
It has been established that signals from the germ line can have a dramatic impact on the 
metabolism of the whole animal. . We hypothesized that the status of the gonad may impact 
the overall rates of de novo synthesis. Therefore, we wanted to assess if the developing 
germline was required for the increase in de novo synthesis observed in the reproductive 
adult. To do this, we utilized the temperature sensitive sterile strain, g/p-1(e2141) that is 
required for the mitotic proliferation of germ cells. Therefore, at 25°C, the g/p-1 animals do 
not form a reproductive germline and have very few germ cells. The g/p-1 animals have 
wild-type levels of fatty acid synthesis at L4; therefore, we used them to test whether oocyte 
production is required to stimulate the increase in synthesis seen at adulthood. We found 
that the g/p-1 animals had increased synthesis at day 1 of adulthood comparable to rates 
measured in N2 and fem-1;fer-15 sterile animals (Figure 4.8). We also found that the 
relative abundance of mmBCFAs increase in the g/p-1 animals between L4 and adult 
suggesting that mmBCFA formation is not regulated by the reproductive germline either 
(data not shown). These results demonstrates that the lipogenic shift is intact in germline-
minus animals suggesting that the upregulation of the de novo fatty acid synthesis pathway 
is independent of the germ line. 
In wild-type animals, there is a large amount of cell division and growth occurring in the 
germline which may suggest that the increases in de novo fatty acid synthesis is a result of 
the increased activity in the gonad. However, the fact that germline minus animals have 
increased levels of fatty acid synthesis and higher abundance of mmBCFAs as adults 
demonstrates conclusively that the increased synthesis seen at this time is not occurring 
specifically in the gonad. 
The Synthesized Fatty Acids Are Preferentially Funneled to the Germline 
Because of the high metabolic demands of reproduction, we thought that the increase in 
synthesis might be required to provide the germline with sufficient quantities of fatty acids. 
We have established that the fatty acids do not contribute preferentially to TAG or PL 
synthesis in the animal, and next, we wanted to test whether the synthesized fatty acids 
themselves could be shuttled preferentially to the germ line to provide adequate fatty acids 
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for the membranes and fat stores of the developing oocytes. In order to test this, we 
compared the distribution of synthesized fats in the whole adult animal versus a population 
of purified embryos. We did this by growing the animals on mixed labeled bacteria and 
retaining a sample for whole animal collection, while hypochlorite treating the remaining 
population of animals to obtain a population of intact eggs. We then extracted total lipid and 
separated the fats into phospholipid (PL) and triglyceride (TAG). In the analysis of the PL 
populations, we did not see any significant change in the distribution of synthesized and 
absorbed fatty acid (Figure 4.9A). This suggested that the synthesized fatty acids are not 
preferentially funneled into the membranes of the germ line. 
However, when we quantified synthesis in the TAG associated fatty acids in the embryo, 
we found a slight but significant difference in the distribution of synthesized fats (Figure 
4.9B). In fact, we believe that this analysis underestimates the contribution of lipogenesis to 
TAG synthesis because we used a fertile strain for this analysis. Therefore, the adults also 
contain embryos, which would lead to an underestimation of the contribution of synthesis to 
embryo TAG. Taken together, we propose a model where de novo synthesis is increased in 
the somatic tissues of the animal to provide extra fatty acids for the gonad. Because free 
fatty acids are transported to the germline, the enrichment of synthesized fatty acids in the 
TAG would suggest that TAG synthesis is occurring at a faster rate than PL synthesis. To 
support this idea, we assessed the lipid composition of the embryos and found that they are 
largely composed of triglyceride with a TAG:PL ratio of 1.3 as opposed to the TAG:PL ratio 
of 0.5 seen in adults (Figure 4.10). 
The Excess Synthesized Fatty Acids May Be Important for Lifespan 
Although we believe that de novo synthesized fatty acids are funneled preferentially to 
the germ line, the relative enrichment is relatively low, suggesting that increased synthesis 
may play another role in the adult. In C. e/egans, the energetic requirements of 
reproduction are quite high with large amounts of cell division and growth occurring in the 
germline compared to the somatic tissues. Because of the demands of reproduction, we 
hypothesized that the lipogenic shift seen in reproductive adults may also function as a 
compensatory mechanism to allow for sufficient fats to be contributed to the maintenance of 
the somatic tissues. To test this hypothesis, we decided to assay the lifespan of animals 
treated with fasn-1 RNAi. Again, the RNAi treatment was initiated 24 hours into 
development. We found that N2 animals treated with fasn-1 RNAi had a reduction in their 
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mean lifespan of -2 days, suggesting that fatty acid synthesis is required for a full lifespan 
(Figure 4.11A). Although the fasn-1 RNAi treatment is initiated before the completion of 
gonad migration, the reduction of lifespan in the g/p-1 animals supports the hypothesis that 
fat synthesis may playa role in the somatic tissues. 
To further test this idea, we have started a lifespan assay with animals put on fasn-1 
RNAi after they reach adulthood (after 48 hours of growth at 25°C). In this preliminary 
analysis, it seems that fasn-1 RNA will result in about the same reduction in lifespan (-1.5 
days) in animals where fatty acid synthesis was compromised only in adulthood. 
Furthermore, we also performed fasn-1 RNAi lifespans with the rrf-1 mutant. rrf-1 encodes 
an RNA-directed RNA polymerase which is required for somatic but not germline RNAi. 
Therefore, using these animals, we can determine the impact of fasn-1 on the germline 
alone. Thus far, our analysis shows that fasn-1 has no impact on the lifespan of the rrf-1 
animals, further supporting the cone/usion that fatty acid synthesis is required in the somatic 
tissues of the adult animal (Figure 4.12). Of course, further studies are needed to determine 
where the synthesized fatty acids themselves are used. Although we can not discount the 
possibility that synthesis plays another important role such as mmBCFA formation in adults, 
we believe this supports the model that the lipogenic transition is important in somatic 
maintenance. 
Because the g/p-1 animals have increased synthesis without the demands of embryo 
production, we hypothesized that the extended lifespan of the g/p-1 animals might be a 
result of the extra lipids synthesized during this period. In fact, when we measure the 
TAG: PL of these animals, we found that they do, in fact, have excess fat storage (up to 2.5x 
more than controls) (Figure 4.13). Interestingly, the g/p-1 animals have wildtype levels offat 
storage at L4 and D1 adult collections, suggesting that the elevated fat storage may be 
directly attributed to the increase in de novo fatty acid synthesis. Also, when the g/p-1 
animals are treated with fasn-1 RNAi, their lifespan is reduced to that of N2 on fasn-1 RNAi. 
The reduction in lifespan demonstrates that fasn-1 is required for healthy aging in the g/p-1 
animals. To us, this suggests a model where the excess synthesized fatty acids may be 
utilized for other demands like tissue maintenance which are normally sacrificed during 
times of reproduction. 
Discussion 
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There is a dramatic change in how animals process their diet during the reproductive 
period resulting in a significant increase in the relative abundance of de novo synthesized 
fatty acids in adult animals. Because many of the known regulators of fatty acid synthesis 
are associated with dauer formation pathways like insulin signaling and TGF-~ pathway 
mutants (Greer et aI., 2008), it may suggest an association such that mutations that inhibit 
reproductive growth result in increased lipogenesis. However, we have shown here that the 
demands of reproduction may require a shift in fat metabolism that results in an increase in 
lipogenesis. The demonstration that reproduction impacts the amount of de novo fatty acid 
synthesis in adult animals reveals a previously unknown function of lipogenesis in C. 
elegans. 
In this study, we sought to determine the role for de novo synthesis during the 
reproductive period, and we found that synthesis contributes to several processes. We 
found that the embryos contained an increased proportion of mmBCFAs, which are 
essential for larval growth (Kniazeva et aI., 2004). Because these fatty acids are fully 
synthesized, we suspected that one of the functions of the increased fatty acid synthesis is 
to provide the embryos with sufficient quantities of mmBCFAs. In order to test this 
hypothesis, fatty acid composition of embryos from mothers treated with fasn-1 RNAi will be 
required. In addition to providing the germline with mmBCFAs, we found an enrichment of 
synthesized fatty acids specifically in the TAG of the embryo. Because the embryo contains 
large quantities of stored fat, we predict that the increase in synthesis is important to provide 
the germline with excess fatty acids. The enrichment of the synthesized fatty acids in the 
TAG suggests that the levels of TAG synthesis in the germ line are higher than PL synthesis 
rates. 
Although both mmBCFA synthesis and the generation of sufficient pools of fatty acids for 
the embryos may be important features of the lipogenic increase, these processes may not 
account for the total increase in de novo fatty acid synthesis. We have found that 
knockdown of fasn-1 gene in adult animals leads to a reduction of their lifespan. Although 
further studies are needed to characterize the impact of fasn-1 RNAi on the animal, we 
propose a model where the increased lipogenesis seen at the onset of reproduction is 
needed to provide enough fatty acids for somatic maintenance (Figure 4.14). We also see a 
reduction of the lifespan of glp-1 animals that do not have a reproductive germline. 
Although the glp-1 animals are normally long-lived, on fasn-1 RNAi, they are as short lived 
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as treated N2. We believe that this reduction in longevity suggests that the increased 
lifespan on the glp-1 animals is a result of the extra resources for somatic maintenance. 
There have been a number of signaling mechanisms described that connect the status 
of the gonad to the metabolism of the whole animal. It seemed likely that a similar 
mechanism was regulating synthesis based on the needs of the germline. Surprisingly, we 
found the lipogenic increase was intact in glp-1 animals that lack a reproductive germline, 
demonstrating that there is not a signaling mechanism relaying the status of the developing 
germ cells. We cannot yet characterize the role of signaling from the somatic germline, 
which has also been established as an important regulator of longevity and may report on 
the status of the germline. However, it has been shown that DAF-12 steroid hormone 
signaling plays an important role in regulation by the somatic germline. Thus, we have 
tested daf-12 mutant animals for the ability to drive the synthesis increase, and, thus far, the 
daf-12 alleles we have tested have the lipogenic shift. This suggests that the somatic 
germline may not be required for lipogenic increase, at least not through the DAF-12 
pathway. In our search for regulators of this increased synthesis, we have indentified a role 
for nhr-69. In animals that overexpress this gene, there is no increase in fatty acid synthesis 
between L4 and adult. Interestingly, these animals have a severely compromised brood and 
a reduction in lifespan, giving support to our model. These results also confirm that there is 
regulation of this increase by genetic factors (See Appendix I). 
Experimental Procedures 
Strains 
The strains used in these experiments were: wild-type N2 (Bristol), CF512: fem-1(hc17);fer-
15(b26) , and CB4037: glp-1(e2141). All strains were maintained at 20°C, and sterile strains 
were shifted to 25°C to induce sterility for the experiments. 
Quantification of Fat Synthesis 
Stable isotope labeling and quantification was performed as previously described ((Perez et 
aI., 2008) and Chapter 2) except that these experiments were performed at 25°C. In order 
to label animals into adulthood, more bacteria was plated (0.5g/plate), and the animals were 
transferred to fresh plates when the food supply was low (-2 to 3 days). Because our 
interest was in the quantification of de novo synthesis and absorption, the % of synthesis 
calculated as: (synthesized FA/(synthesized FA + dietary FA»*1 00. 
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Lipid Extraction and Column Separations 
Lipid extraction and detection was performed as described (Perez et aI., 2008). 
Analysis of Embryos 
In order to quantify relative fatty acid synthesis, fatty acid composition and fat storage 
numbers, a population of purified embryos was harvested. To do this, we grew a population 
of nematodes to adult on mixed isotope plates (prepared as described in (Perez et aI., 2008) 
and Chapter 2) and then hypochlorite treated the animals to harvest the eggs. Standard 
bleaching techniques were utilized with a 20% bleach solution. 
Brood and Lifespan Analysis 
To bypass the fasn-1 RNAi induced larval arrest, synchronized L 1 s were transferred to 
L4440 control bacteria for 24 hours before being transferred to fasn-1 RNAi bacteria for the 
duration of the experiment. Brood analysis was conducted by transferring the animals to 
fresh plates each day and counting the laid embryos (for fasn-1 treatment) or the hatched 
L 1 s (for L4440 control treatment) after 24 hours. The same RNAi strategy was implemented 
for lifespan analysis. Any bagged or lost animals were not included in the totals. 
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Figure 4.1. Increased Synthesis in Adult Nematodes: (A) The amount of fatty acid 
synthesis is almost doubled between the late L4 (grey) stage and day 1 adult (shown 
in black) . The increase in synthesis is found in all components of the C20 PUFA 
pathway but not in the fatty acids of the C18:1n7 synthesis pathway. Data shown is 
from purified phospholipids with at least 4 experiments. SEMs are shown. (8) 
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Figure 4.2. Synthesis Continues to Increase in First Days of Adulthood: Animals 
were grown on mixed isotope media into adulthood, and we found that the relative 
abundance of synthesized palmitate continues to increase while the animal is still 
laying eggs. Data shown is from purified phospholipids with at least 3 experiments 
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Figure 4.3. Synthesis Over Adulthood: Using fem-1;fer-15 animals, we quantified 
synthesis over adulthood for C16:0 (A) and C18:2n6 (8). Data shown is for both 














Figure 4.4. Number of Embryos Produced in fasn-1 Treated Animals Is 
Normal: In order to determine if germ cell number was affected by fasn-1 
RNAi treatment, we grew larvae past the L 1 arrest point (24hr) on control 
bacteria (L4440) and then plated them on fasn-1 RNAi. Control animals were 
transferred at this point to fresh L4440 plates. The number of laid embryos 
was then counted. Experiments were performed at 25° and progeny from 5 
animals were counted. 
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Figure 4.5 Germline Progression Is Normal With fasn-1 Treatment: In 
order to determine if the gonad arms could progress normally without fasn-1, 
we switched animals to fasn-1 after 24hr of growth at 20°C. DIC microscopy 







'u _ 25.00 
<C~ 
~ ,9- 20.00 
C'tI 0 
~ a 15.00 
C'tI II) 
~ ~ 10.00 
'tooa. 





u 8.00 <C 
~ 




'too 2.00 0 
~ 0 
0.00 




.. C/) C .. C/) .. c c c" c c c c ~ .- ~ <.0 .- ~ co N ~ ~ co ~ ~ L(') (") ~ ~L(') •• ~I'- ~ ...... ~ ....... . 
o~<.Oo~oocococooooooo 
\,.J~ \,.J ~~~ NNNN 




u 8.00 <C 
~ 




'too 2.00 0 
~ 0 
0.00 
C15iso C17iso C15iso C17iso 
Figure 4.6. Increased mmBCFAs in Embryos: (A) Although the fatty acid 
composition of the animals does not change dramatically between L4 (grey) and day 1 
adult (black), there are two significant changes: (I) decreased abundance of palmitate 
(C16:0) and (II) increase in the relative abundance of C17iso. We then measured the 
relative abundance of the mm8CFAs in the embryos and found a slight but significant 
increase in the C151S0 content in phospholipid (8) and increased abundance of both 
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Figure 4.7. Synthesis Contributes Equally to PL and TG Formation: Relative 
synthesis is equal in the phospholipid (purple) and triglyceride (grey) populations of the 
nematode at L4 (lighter shades) and in day 1 adults (dark). Data shown is from at 
least 3 experiments with SEM shown. 
78 
18.0 
..- 16.0 0 




- N2 Q) 
..c 8.0 fem1 ;fer15 ...... c 
>. 6.0 
. glp1 CJ) 
'+- 4.0 0 
-;:R. 0 2.0 
0.0 
late L4 day 1 adult 
Figure 4.8: Elevated Synthesis Is Independent of Production of 
Functional Oocytes. The rates of palmitate synthesis in germline minus 
g/p-1 animals (blue) is comparable to wild-type (N2) animals (shown in 
black) and fem-1 ; fer-15 mutants (green), indicating that the increase in 
lipogenesis is independent of a reproductive germline. Data shown is from 
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Figure 4.9: The Relative Synthesis in Embryos Is Increased in TAG. The relative 
amount of synthesized fatty acids is equivalent in embryos (purple) and in adults (blue) 
in a purified phospholipid population (A). However, there is a significant increase in 
the relative abundance of synthesized fatty acids in certain species in triglycerides 
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Figure 4.10. Embryos Have A High TAG:PL Ratio: To assess the relative 
abundance of the lipid classes, we separated lipids by column chromatography for 
adults (red) and bleached embryos (blue). This analysis demonstrated a significant 
increase in the abundance of TAG in the embryos compared to the adult population. 
Additionally, because the adults contain embryos, this difference is an underestimate. 
The method for purifying embryos is described in experimental procedures. Data 
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Figure 4.11. fasn-1 Results in Reduction of Lifespan: (A) fasn-1 RNAi treated 
was initiated after 24hr of larval growth. The fasn-1 RNAi resulted in a reduction of 
lifespan in N2 and in g/p-1 animals. (8) Lifespan analysis of fasn-1 RNAi was initiated 
after 48hr of growth. The trends seen with both 24hr and 48hr RNAi initiation appear 
to be the same. Curves from three replicates, each with a minimum of 25 animals. All 
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Figure 4.12. fasn-1 in the Germline Does Not Reduce Lifespan: fasn-1 RNAi 
treatment was initiated after 48hr of larval growth in rrf-1 animals. There is no difference 
between the lifespan of rrf-1 animals on control RNAi (black) or fasn-1 RNAi (red), 
supporting the conclusion that FASN-1 plays a role in the somatic tissues. All lifespans 
were performed at 25°C. Curves were generated from a minimum of two replicates with at 
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Figure 4.13. TAG Storage in Adult Animals: Sterile adults were harvested at the 
noted day of adulthood. Total lipids were then extracted and separated into neutral 
lipids (TAG) and phospholipids (PL). Internal standards were used to correct for 
recovery and the TAG:PL ratio was calculated for wild-type N2 (grey), fem1;fer15 
animals (blue) and g/p1 mutants (dark green). Although g/p-1 TAG:PL ratio is 
relatively normal at L4 and day 1, there is a significant increased in the fat stores of 
these animals after day 2. Data show is from a minimum of three experiments and 
SEM is shown for fem-1;fer-15 and g/p-1 animals. The data for N2 represents two 
experiments although those animals have been analyzed in similar experiments 











Figure 4.14. Model for Role of Fatty Acid Synthesis in Reproduction: Fatty acid 
synthesis is increased to generate adequate pools of fatty acids. These fatty acids are 
funneled to the germline where they are used primarily for TAG synthesis. Any surplus 
fatty acids can be used for the other functions of the animal like somatic maintenance. We 
predict that when fatty acid synthesis is compromised, all fatty acids are funneled to the 
germline, leaving few resources for somatic maintenance. 
85 
CHAPTER V: Reduced Oxidative Phosphorylation Drives Lipogenesis in C. e/egans 
Summary 
In the 1920s, it was established that cancer cells have a dramatic change in their overall 
metabolism. Unlike normal cells, cancer cells stop utilizing fat for energy and begin to rely 
almost exclusively on sugar breakdown. It has been proposed that this metabolic shift 
results in a growth and survival advantage for the tumor. Another key feature of cancers is 
that this glycolytic metabolism is accompanied by a tremendous increase in de novo fatty 
acid synthesis. In the redox balance hypothesis, this elevated lipogenesis has been 
suggested to be a compensatory mechanism that is required for the change in primary 
energy sources from fat to sugar. Namely, fatty acid synthesis is elevated to restore NAD+ 
levels necessary to run glycolysis; however, it is not clear what drives lipogenesis in cancer 
cells. Here, we describe our establishment of nematodes as a model of cancer cell 
metabolism that will allow us to address many important yet unanswered questions about 
lipid metabolism in glycolytic states. Using a stable isotope based quantification method, we 
have found that compromised oxidative phosphorylation is a primary driver of de novo fatty 
acid synthesis. Additionally, we have quantified lipogenesis in a number of electron 
transport chain mutants (c/k-1, isp-1, and mev-1) and have found a correlation between 
NAD+:NADH metabolism and increased de novo fatty acid synthesis. The genetic 
tractability of C. e/egans has allowed us to identify the hypoxia inducible factor, HIF-1, and 
the transcription factor, DAF-16, as potential mediators of this lipogenic increase. We 
believe that the nematode will be valuable in probing the activity of different metabolic 
pathways using stable isotope labeling feeding approaches. 
Introduction 
Each cancer has a unique set of affected genes and pathways that affect its formation, 
progression, and metastatic potential; however, there are several unifying features that are 
constant in the vast majority of cancers. One of these hallmarks was first observed by Otto 
Warburg in the 1920s when he observed that tumors rely heavily on glycolysis for the 
generation of energy even in the presence of ample oxygen (Warburg et aI., 1927). The 
reprogramming of energy metabolism to aerobic glycolysis has been observed in the vast 
majority of tumors tested, and, in fact, the sugar-fueled metabolism is the basis of the PET 
scan detection methods. The early observation of aerobic glycolysis in cancers has 
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withstood the test of time, and the Warburg metabolism of tumors has recently been 
characterized as an emerging hallmark of cancers (Hanahan et aI., 2011). However, to run 
this type of metabolism, there are additional changes in metabolic pathways that are 
required. 
The aerobic glycolysis of the tumor coincides with a severe reduction in the rates of 
oxidative phosphorylation. This decreased electron transport chain activity results in the 
accumulation of NAOH as its electrons are no longer donated to complex I to drive the 
formation of a proton gradient. As the imbalance of NAOH:NAO+ becomes greater, the cell 
must initiate pathways to regenerate NAO+ levels in order to continue to run glycolysis 
which is essential for their survival. One of the ways to regenerate NAO+ is through lactate 
production by lactate dehydrogenase activity. The lactate produced is then excreted from 
the cell. However, fatty acid synthesis is another way to regenerate NAO+ levels, and 
another key feature of tumors is that there is a switch from dietary fat incorporation to de 
novo fatty acid synthesis. 
In normal cells, de novo fatty acid synthesis is minimal contributing only about 10% of 
the total fatty acids; however, in cancers, fat synthesis is the primary source of fats 
contributing over 90% of the total fat available (Menendez et aI., 2007). Expression of the 
main fatty acid synthesis enzyme, fatty acid synthase (FASN) is upregulated in many 
cancers as demonstrated by immunohistochemistry studies (Kusakabe et aI., 2002). In fact, 
this increase in lipogenesis is one of the most frequent alterations in cancers and has been 
observed in the majority of cancer types tested including prostate, breast, stomach and lung 
cancer (Menendez et aI., 2007). 
The restoration of the redox balance with fat synthesis may provide several distinct 
advantages to the cancer cells including elimination of the need for high levels of potentially 
destructive acids. Additionally, growing tumors require high levels of phospholipid synthesis 
and the increased synthesis of fatty acids would help to provide the fatty acids necessary for 
membrane synthesis. In support of this role, membrane phospholipids in cancer cells have 
been shown to have more synthesized fatty acids associated with them than control cells 
(Hilvo et aI., 2011). Both high glycolytic and lipogenic activity provide the cancer with a 
survival advantage, and these metabolic shifts are associated with higher risk of disease 
reoccurrence and death (Menendez et aI., 2007). In fact, the advantages of aerobic 
glycolysis are somewhat counterintuitive as reduced respiration also results in a decrease in 
the production of ATP; however, this metabolic shift may help to facilitate the rapid 
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generation of biomass needed in growing tumors (Vander Heiden et aI., 2009). Because 
these processes are limited in normal cells, genes involved in the glycolytic and lipogenic 
transition may provide selective targets for the treatment of cancers. Because these 
changes are important for the survival of the tumor, disruption of either process results in 
cancer inhibition in mouse models and cell culture systems. However, a better 
understanding of the genes and pathways necessary for the metabolic changes will benefit 
treatment options in the future. 
Although it has been established that de novo fatty acid synthesis is increased in the 
majority of cancers, the drivers of this lipogenic shift have not be elucidated. One 
hypothesis is that the hypoxic conditions in the tumor environment may lead to the increase 
in FASN expression. Adaptations to hypoxic environments are mediated by the hypoxia 
inducible factor, HIF-1, which activates a suite of genes and pathways needed for survival in 
low oxygen environments. One of HIF-1's targets is the fasn-1 gene, which suggest that the 
increase in lipogenesis is an important response to low oxygen environments. However, it 
has also been shown that HIF-1 can activate its targets independent of oxygen availability 
by acidosis and reactive oxygen species (Lee et aI., 2010; Menendez et aI., 2007). Because 
signaling pathways and metabolite levels also impact lipogenesis, these factors must be 
considered as well. 
We have established a stable isotope labeling strategy that allows us to monitor the 
dynamics of fatty acid metabolism (Chapter 2 and (Perez et aI., 2008)). Here, we wanted to 
apply this method to see if we could mimic the changes seen in cancer cell metabolism. 
This manipulation would give us a genetically tractable system for identifying genes and 
metabolic pathways that are important for cancer cell metabolism. Here, we have used C. 
elegans to describe an increase in lipogenesis that mirrors cancer cells and to identify genes 
that impact this transition. 
Decreased Oxidative Phosphorylation Drives De Novo Fatty Acid Synthesis 
In cancers, the glycolytic state has been hypothesized to be a result of hypoxia and/or 
mitochondrial dysfunction. Because both of these perturbations impact oxidative 
phosphorylation, we wanted to determine the role of the electron transport chain on fatty 
acid synthesis using a mixed isotope labeling assay (described in Chapter 2). To do this, 
we measured the amount of synthesis in a mutant with diminished electron chain activity. 
The clk-1 gene encodes a demethoxyubiquinone (DMQ) hydroxylase that is required for the 
88 
synthesis of coenzyme Q (ubiquinone) which functions to transport electrons from Complex I 
to Complex III in the electron transport chain (Figure 5.1). The clk-1 animals have been 
shown to have a mild reduction in the rates of mitochondrial respiration along with lifespan 
extension and slow growth phenotypes (Braeckman et aI., 2009). We grew this animals on 
mixed isotope labeling plates to determine rates of de novo fatty acid synthesis. We found a 
-70% increase in palmitate synthesis and a -80% increase in stearate synthesis in clk-
1 (qm30) animals (Figure 5.2). Because the elevated synthesis is seen upon perturbation of 
oxidative phosphorylation, this result effectively demonstrates that decreased oxidative 
phosphorylation leads to an increase in de novo fatty acid synthesis. 
Because ubiquinone has other functions within the cell, we also assayed synthesis rates 
in isp-1(qm150) worms which have a structural defect in complex III of the electron transport 
chain. In isp-1 animals, we found that there is an even greater increase in synthesis with a 
125% increase measured in palmitate which confirms that the lipogenic phenotype is due to 
decreased oxidative phosphorylation and not off target effects (Figure 5.2). Because the 
isp-1 animals have a more severe reduction in respiration, we believe this suggests there is 
a dosage dependent effect defining the rates of fatty acid synthesis based on the degree of 
oxidative phosphorylation inhibition. Taken together, this suggests that the elevated fatty 
acid synthesis observed is direct result of decreased electron transport chain activity. 
Additionally, the increased synthesis observed in nematodes with compromised oxidative 
phosphorylation suggests that C. elegans is a useful model for studying cancer metabolism. 
The Impact of NADH:NAD+ Metabolism on Fatty Acid Synthesis 
Because we found that defects in coenzyme Q (clk-1) and complex III (isp-1) resulted in 
increased lipogenesis, we wondered whether any decrease in mitochondrial respiration 
would cause increased fat synthesis. In addition to decreasing the function of the ETC, 
coenzyme Q and complex III deficiency would also lead to the backup of both types of 
reducing equivalents, NADH and FADH2 (succinate). Therefore, we tested whether the 
increased fat synthesis was a result of a reduction in oxidative phosphorylation directly or an 
imbalance of metabolites namely NADH and/or FADH2. To do this, we measured de novo 
synthesis in mutants for the succinate dehydrogenase of Complex II, mev-1. Because mev-
1 is required to accept electrons from succinate, these animals allowed us to test whether 
succinate buildup causes increased lipogenesis. These mev-1 animals did not show any 
increase in fatty acid synthesis, suggesting that succinate imbalances do not impact 
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lipogenesis (Figure 5.2). This result also demonstrates that fatty acid synthesis is not a 
response to a generalized decrease in mitochondrial respiration function. However, the 
impact of succinate on the ETC has not been established in nematodes, so further 
experiments are required to determine if compensation by the NADH pathway can relieve 
the requirement of succinate. 
In order to test if the reverse is true and the succinate pathway can compensate for a 
reduction in the NADH pathway, we quantified lipogenesis in animals treated with rotenone, 
a Complex I inhibitor. In doing so, we found a dose-dependent increase in fat synthesis 
upon rotenone treatment (Figure 5.3). The lipogenic response upon Complex I inhibition 
demonstrates that the succinate pathway cannot compensate for a reduction in NADH 
metabolism. Additionally, this result demonstrates that there is a graded response to 
reduced ETC activity, which is consistent with the graded synthesis increase observed in the 
clk-1 versus isp-1 animals. In considering the components of the ETC that we have tested 
thus far, we believe that our data suggests a role for the ratio of NADH:NAD+ in the 
regulation of fatty acid synthesis upon inhibition of oxidative phosphorylation. 
The Role of HIF1 in Regulating Synthesis 
To identify genes that are essential for the increased lipogenesis, we began by testing 
the requirement of the HIF-1 transcription factor for this adaptation. A recent study 
demonstrated that the hypoxia-inducible factor HIF-1 is required for the lifespan extension 
seen in clk-1 and isp-1 animals, suggesting that HIF-1 is active in these ETC mutants (Lee 
et aI., 2010). Although the main HIF-1 stabilization mechanism is mediated by limited 
oxygen conditions, this group demonstrated that the impaired respiration increases HIF-1 
activity under normoxia (Lee et aI., 2010). In mammalian cell culture, HIF-1 has also been 
described to regulate FASN-1 through the SREBP transcription factor (Furuta et aI., 2008). 
Therefore, we tested the involvement of the hypoxia-inducible factor (HIF) in mediating the 
lipogenic response to ETC inhibition. To do this, we quantified synthesis in hif-1 (ia04) 
mutant animals treated with the Complex I inhibitor, rotenone. The untreated hif-1 mutants 
have wildtype levels of synthesis suggesting that HIF-1 does not regulate de novo synthesis 
under normal conditions. However, there is no increase in de novo synthesis when they are 
treated with rotenone (Figure 5.4). Under the conditions used, the wild-type animals have 
over 2x the amount of synthesized palmitate. This result suggests that hif-1 is the main 
driver of lipogenesis when the electron transport chain is inhibited. Because we performed 
90 
these experiments in oxygen-replete conditions, the stabilization of HIF-1 by hypoxia is not 
required for the increase in synthesis. 
The Interactions Between Electron Transport Chain Mutants and the Insulin/lGF 
Signaling Pathway 
The FoxO transcription factor homolog, DAF-16, is activated by stress and nutrient 
depletion, and because we have already established that daf-16 is a regulator of fat 
synthesis (see Chapter 2 and (Perez et aI., 2008)), we wanted to test its involvement in 
regulating lipogenesis when mitochondrial respiration is inhibited as well. To do this, we 
quantified synthesis in both clk-1 (qm30);daf-16(m26) and isp-1 (qm150);daf-16(m26) double 
mutants. In preliminary experiments, we found a reduction in amount of palmitate synthesis 
in both strains although the decrease was greater in the clk-1 ;daf-16 animals (Figure 5.5A). 
This suggests that the full upregulation of fatty acid synthesis requires not only the activity of 
HIF-1, but also the activity of DAF-16. 
Next, we tested if the reduction of electron transport chain activity could further increase 
the elevated fatty acid synthesis seen in mutants of the DAF-2 insulin receptor. In the clk-
1;daf-2 animals, we found that these pathways were partially additive, suggesting that the 
function, at least, in part through different mechanisms (Figure 5.58). However, the isp-
1;daf-2 double mutants have decreased synthesis compared to either of the parent strains 
(Figure 5.58). Although further study is required to determine how these pathways impact 
lipogenesis, the different interactions of the clk-1 and isp-1 gene with the insulin/lGF 
pathway suggests that isp-1 and clk-1 may regulated lipogenesis through distinct 
mechanisms. 
Using C. eJegans to Probe the Function of TCA Cycle Intermediates 
Under normal respiring conditions, the TCA cycle functions to produce reducing 
equivalents that are then converted to ATP by oxidative phosphorylation. There is no net 
loss of carbon through the TCA cycle; however, when oxidative phosphorylation is 
compromised, the intermediates of the TCA cycle can be diverted to other metabolic 
pathways. In order to generate fatty acids, there needs to be a supply of carbon as well as 
NADPH. Using C. elegans and rotenone treatment, we are now able to test the 
requirements of alternative metabolic pathways for fatty acid synthesis induced by 
decreased mitochondrial respiration. 
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The glyoxylate cycle is an anabolic pathway that allows the generation of sugar from fat. 
This pathway bypasses several step in the TCA cycle that result in carbon loss via CO2 , We 
reasoned that this cycle may be akin to glutamine feeding into the TCA cycle, which is 
thought to be a critical pathway for cancer cell metabolism. To test the requirement of the 
gei-7 gene in inducing fatty acid synthesis, we quantified fatty acid synthesis in animals 
subjected to rotenone treatment. In gei-7 animals, there is a synthesis increase upon 
rotenone treatment, suggesting that the glyoxylate pathway is not required for lipogenic 
metabolism with reduced oxidative phosphorylation (Figure 5.6). However, this experiment 
indicated that we can effectively probe the requirement of various metabolic pathways in 
oxidative phosphorylation compromised nematodes. 
Discussion 
In ETC mutants, we have found a dramatic increase in the relative abundance of de 
novo synthesized fatty acids. In these animals, there is reduced oxidative phosphorylation 
and therefore an increased reliance on glycolysis. One of the primary effects of this altered 
metabolism is the accumulation of NADH whose electrons are no longer donated to 
Complex I of the ETC. Because NAD+ is no longer produced at Complex I, adequate NAD+ 
pools must be restored by lactic acid production or by fatty acid synthesis. In fact, we found 
that mutations in the ETC that do not impact NADH:NAD+ ratio, mev-1 animals, do not have 
increased fatty acid synthesis. This altered metabolic state mirrors very closely the 
metabolism of cancer cells which are known to rely primarily on glycolysis and have also 
been shown to have very high rates of fat synthesis. The ability of FASN to restore the 
NADH:NAD+ ratio has been described in the "Redox Imbalance Hypothesis", and we 
believe that the increase in fatty acid synthesis associated with decreased oxidative 
phosphorylation provides a genetic model for the study of cancer cell metabolism. In 
support of this model, studies on the effect of rotenone of lipogenesis in the 1960s found 
that rates of fatty acid synthesis were linearly related to the resulting NADH:NAD+ ratio with 
rotenone treatment in rabbit heart mitochondria (Hull et aI., 1967). Future studies on the 
relative importance of lactate synthesis and lipogenesis will be important to a full 
understanding of this altered metabolism. 
Our finding that the HIF-1 transcription factor is important in regulating the lipogenic 
response to decreased oxidative phosphorylation suggests that oxygen availability may also 
impact synthesis rates. In fact, studies in C. e/egans have found an increase in fat storage 
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after anoxia treatment through the SREBP (~terol Response ~Iement ,6,inding 2rotein) 
transcription factor (Taghibiglou et aI., 2009). Early experiments have found a role for 
SREBP in mediating the synthesis increase we see with decreased electron transport chain 
activity (data not shown). Although we have shown that the influence of HIF-1 on fat 
synthesis is independent of oxygen availability, this response pathway may also respond 
directly to a reduction in oxygen levels. Hypoxic cycles have been demonstrated to be a 
feature of the tumor environment which suggests that low oxygen availability may influence 
fat synthesis in tumor cells as well. Our attempts at measuring synthesis in worms grown in 
hypoxia have, thus far, been inconclusive. 
The increase in lipogenesis in cancer cells requires the activity of several other 
pathways; however, the relative importance of these pathways has not been fully 
investigated. For example, there are several enzymatic reactions that produce NADPH 
including the pentose phosphate shunt, the malic enzyme and isocitrate dehydrogenase. 
Using the nematode and isotope flux analysis, it will be possible to determine the relative 
importance of each of these pathways as well as if they can compensate for each other. 
Additionally, although it is clear that glutamine is a contributor to the TeA cycle during 
glycolytic periods, the same setup can be utilized to determine how glutamine impacts the 
metabolism of the cell (Figure 5.7). 
The identification of mediators of this lipogenic transition will allow for studies to 
interrogate the importance of these pathways in nematode survival under reduced oxidative 
phosphorylation. We predict that de novo synthesis may be an important response to 
hypoxic environments. In support of this idea, different daf-2 animals have distinct 
resistance to hypoxia, and there is a correlation between the degree of hypoxia resistance 
and amount of de novo fatty acid synthesis (Mabon et aI., 2009). 
Although cancer cells are a clear example of decreased electron transport chain 
activity, there are other contexts where these studies would be informative. For instance, 
chronic exposure to hypoxia in individuals with sleep apnea or asthma has been associated 
with increased incidence of obesity. Moreover, in nematodes, exposure to anoxic 
environments results in an accumulation of fat storage. This fat accumulation is dependent 
on the activity of the transcription factor SREBP that is known to regulate the fatty acid 
synthase gene. Taken together, hypoxia induced fat accumulation may be explain the 
increase of de novo fatty acid synthesis when the electron transport chain is compromised 




The strains used in these experiments were maintained at 20°C. The strains provided by 
the Caenorhabditis Genetics Center (CGC) are: N2 Bristol, CB4876: clk-1(e2519), MQ130: 
clk-1(qm30) and MQ887: isp-1(qm150), TK22: mev-1(kn1), RB766: gei-7(ok531), ZG31: hif-
1 (ia 04) , MQ1050: isp-1 (qm 150);daf-16(m26), MQ876: isp-1(qm150);daf-2(e1370), XXX: clk-
1(qm30);daf-16(m26) and MQ513: clk-1 (e2519);daf-2(e 1370). 
Mixed Isotope Feeding Assay, Lipid Purification and Analysis 
All experiments were performed as described in the Experimental Procedures in Chapter 2. 
Because many of these strains are slow growing and have some asynchronous 
development, the animals were harvested when the majority of the worms were at mid-L4. 
These experiments were conducted before our discovery of the increase in synthesis that 
coincides with the onset of adulthood (discussed in Chapter 4); therefore, more carefully 
staged collections would be warranted to ensure accurate synthesis numbers. 
Rotenone Treatment 
A rotenone stock was made at 0.5 mg/ml in DMSO, and top spread on the mixed labeled 
plates. The rotenone stock was made fresh for each experiment as we found significant 
variability that we attributed to instability of the drug. Inconsistencies were still seen 
between experiments. Therefore, with each experiment, a titration was performed. 
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NADH 
Figure 5.1: Schematic of the Electron Transport Chain. Electrons are donated 
from NADH to Complex I of the ETC to drive the formation of a proton gradient that is 
ultimately utilized to produce ATP. The electrons are transferred from Complex I 
through coenzyme Q to Complex III. There is an alternate pathway involving the 
transfer of electrons from FADH2 to Complex II and then to coenzyme Q. Strains with 
mutations in genes encoding components of the ETC were used in this study: mev-1 
(Complex II), clk-1 (coenzyme Q) and isp-1 (Complex III). 
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Figure 5.2. Decreased Mitochondrial Respiration Leads to Increased Synthesis: 
Inhibition of complex I (by rotenone), coenzyme Q (clk-1) and complex III (isp-1) all 
lead to increased synthesis. However, inhibition of complex II (mev-1) results in 
normal palmitate synthesis suggesting that lipogenesis is linked to imbalance of 
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Figure 5.3. Dose-dependent Increase in Lipogenesis With Inhibition 
of Complex I: In order to test the requirement of Complex I activity on de 
novo fatty acid synthesis, we grew animals on rotenone, a Complex I 
inhibitor. We found that not only does palmitate synthesis increase with 
rotenone treatment, but it does so in a dose-dependent manner. The 
curve shown is from one experimental set, but the trend has been 


















Figure 5.4. HIF1 is Required for Rotenone Induced Lipogenic Increase: In wild-
type (N2) animals, rotenone treatment results in a >2-fold increase in C16:0 synthesis. 
However, hif-1(ia04) animals do not have increased synthesis on rotenone (-1.1-fold). 
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Figure 5.5. Interaction Between the ETC and Insulin Signaling Pathway: (A) Using 
double mutants, we have found that daf-16 function is required for the increased 
lipogenesis of ETC mutants. (8) The clk-1;daf-2 animals demonstrate that these 
pathways are partially additive; however, the isp-1;daf-2 animals have lower synthesis 
than either parent. Although these experiments need to be repeated, it suggests that 
clk-1 and isp-1 may be regulating synthesis differently. Confirmation of these interactions 
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Figure 5.6. gei-7 Mutants Increase Synthesis With Rotenone 
Treatment: We found that the gei-7(ok531) mutant responds 
normally to rotenone treatment. Synthesis rates were normalized to 





















... c ~ ~ 












Figure 5.7. NADPH Generating Pathways: There are multiple enzymes that can be 
used to generate NADPH needed for lipid synthesis (highlighted in green). Other 
pathways including the glutamine pathway and glyxoylate shunt can also be tested for 
their role in cancer cell metabolism using the nematode and rotenone inhibition. 
Combining genetic mutants with reduction of ETC activity will allow us to begin to 
understand the relative importance of each of these metbaolic pathways. 
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CHAPTER VI: Conclusions and Future Directions 
Summary 
We believe that the implementation of stable isotope technology in a model organism such 
as C. e/egans will allow for the exploration of many fundamental questions about fatty acid 
metabolic regulation that have not yet been able to be addressed. We have demonstrated 
that the mixed labeling technology can be utilized to learn more about how known regulatory 
pathways like the insulin/lGF signaling pathway impact fatty acid metabolism. Additionally, 
this strategy can also be implemented to identify previously unrecognized connections such 
as the role of electron transport chain activity and reproduction in the regulation of de novo 
synthesis. Not only can these isotope labeling strategies be used to continue to understand 
fatty acid metabolism pathways, but the implementation of feeding stable isotopes in the 
nematode can also be expanded to address different aspects of fatty acid metabolism and 
to quantify changes in other cellular components like proteins and DNA. 
Origins of Fatty Acids in C. e/egans 
In this work, we have been able to define the sources of fatty acids in wild-type C. 
e/egans for the first time. We have established that, like mammals, the worm derives the 
majority of its fat directly from the diet, and the proportion of de novo synthesized fatty acids 
is minimal for most fatty acid species. Because we can achieve high levels of isotope 
enrichment in the animal, we can measure the contribution of synthesis to all the different 
types of fatty acids. In doing so, we have found an enrichment in synthesized fatty acid in 
the polyunsaturated species (PUFAs) which suggests that de novo fatty acid synthesis may 
play an important role in the generation of membrane lipids. Future work is necessary to 
fully establish this function as high fragmentation of longer chain PUFAs in the mass 
spectrometer makes their analysis difficult. 
Because the development and lifespan of the nematode is relatively short, C. e/egans 
offers a unique opportunity to study how fatty acid metabolism changes over development 
and aging. Thus far, we have found a dramatic shift in how an animal processes its diet as 
a larva and as a reproductive adult. However, it will be important to characterize how an 
organism processes its diet at all life stages. In particular, the aged animal has a 
tremendous reduction in feeding rate, and it will be important to define which lipid 
processing pathways are intact at that stage. 
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Characterization of Fat Storage Mutants 
In addition to characterizing fatty acid metabolism in wild-type C. elegans, this mixed 
labeling approach can also be used to determine how fat storage genes impact metabolic 
pathways. This ability may be particularly useful because there have been hundreds of 
genes identified that impact fat accumulation; however, defining how each gene impacts 
lipid physiology is essential for the continued understanding of the regulation of fat storage. 
We have demonstrated that the mixed isotope technology can be used to determine if a high 
fat mutant has increased fat absorption, increased fatty acid synthesis or decreased fat 
utilization. Moreover, we have used the mixed labeling approach to characterize the cause 
of the altered fat accumulation in several mutant backgrounds (Figure 6.1). For example, 
we have determined that the elevated fat storage observed in daf-2 animals can be largely 
attributed to the increased fatty acid synthesis seen in these mutants. Not only will this 
method allow for these genes to be defined much more quickly than through standard 
transcriptional analysis, but the large amount of data will also allow for a more thorough 
understanding of how each gene impacts the lipid physiology of the nematode. 
Additionally, we have undertaken a limited screen of high fat mutants and have identified 
several new regulators of de novo fatty acid synthesis including peroxisomal ~-oxidation 
genes (Appendix I). Because the majority of the key metabolic pathways including de novo 
synthesis, ~-oxidation, and fat absorption are homologous to mammalian systems, we 
believe that the definition of genes in nematodes will impact the understanding of obesity 
and metabolic disease in humans. In that regard, we have established that chemicals that 
inhibit mammalian metabolic pathways, like rotenone and orlistat, also are efficacious in C. 
elegans. 
C. eJegans As a Model System for Studying Fat Metabolism 
We believe that the capability to conduct isotope flux analysis will be critical in the 
continued development of the nematode as a model for studying fat storage and 
metabolism. This is especially true in light of the fact that many of the current tools available 
for measuring fat storage have come under scrutiny as of late. Lipophilic dyes like Nile Red 
have been utilized to characterize fat storage and to screen for new regulators of fat 
storage; however, recent studies have shown that this dye primarily stains lysosome-related 
organelles, which are not the primary fat stores of the nematode (O'Rourke et aI., 2009; 
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Zhang et aI., 2010). Nile red screen shave identified many genes that have impacts on fat 
metabolism that have been confirmed by other methods including biochemical analysis; 
therefore, the mixed isotope labeling method that we described may contribute to a better 
understanding of other fat storage tools by allowing us to look directly at the dynamics of the 
fatty acids themselves. 
Furthermore, we can look at defined populations of lipid molecules to characterize the 
metabolism of triglycerides and phospholipids separately. Because we combine metabolic 
labeling with gas chromatography/mass spectrometry, we can quantify the relative ratio of 
synthesized and absorbed fatty acids, the composition of the fatty acids in the TAG and in 
the PL, and the TAG:PL, a preferred method for measuring fat storage, all in a single 
sample. For these reasons, we believe that this method will be useful in determining how 
particular genes and pathways disrupt fat metabolism. 
Identification of Genes and Pathways that Impact Fatty Acid Metabolism 
The implementation of flux analysis in the fat of the nematode has allowed us to further 
define how key regulatory pathways impact fatty acid metabolism. In this work, we have 
expanded the knowledge of fat metabolism by studying the impact of genetic pathways on 
total dynamics. We were able to define how the insulin signaling pathway impacts lipid 
metabolism more accurately by tracing the utilization of the diet as opposed to relying only 
on transcriptional changes. We believe that this method will continue to be useful in 
describing complex genetic pathways that regulate fat metabolism. 
This type of isotope analysis has also allowed us to determine how changes in 
metabolite balances impact interacting metabolic pathways. The best example of this type 
of study is the interrogation of how oxidative phosphorylation impacts fatty acid metabolism 
where we uncovered a relationship between the ratio of NADPH to NAD+ and the rate of 
fatty acid synthesis. However, there is much more to learn about how different pathways 
interact in animals. For example, we do not know which enzymes are important for the 
generation of acetyl-CoA from TCA intermediates. Using RNAi in conjunction with isotope 
tracers, it is possible to monitor how perturbations in one pathway impact other metabolic 
fluxes. 
The Impact of Fatty Acid Synthesis on Fat Storage and Lifespan 
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One of the major advances of this work was the description of how de novo fatty acid 
synthesis impacts fat storage and lifespan. We found that the levels of fatty acid synthesis 
have a dramatic influence on the total fat stores of the animal. Although it is not surprising 
that making more fat would result in elevated fat stores, the impact on total fat accumulation 
was larger than expected. Because de novo fatty acid synthesis is normally quite minimal, 
even modest increases in the rates of synthesis (-30 to 50% total) account for more than 
60% of the increased fat stores. In fact, we believe that this number is conservative as 
increased lipogenesis can feed back and inhibit mitochondrial ~-oxidation resulting in 
reduction of fat utilization as well. 
Our studies also allowed for us to genetically separate fatty acid synthesis and longevity. 
Because many pathways like the insulin/lGF pathway regulate both lifespan and fat 
metabolism, it made intuitive sense that the changes in fat metabolism might be essential for 
the increased longevity. However, our studies with a series of daf-2 mutant alleles allowed 
us to determine that lifespan and fat synthesis were genetically separable. This result is 
encouraging for the future development of drugs that can target fat storage without 
negatively impacting longevity and vice versa. However, we and others have established a 
potential role for de novo fatty acid synthesis in reproduction (Chirala et aI., 2003). Also, in 
our studies, we have found an additional role for fasn-1 in regulating adult lifespan which will 
need to be considered before attempting such interventions. 
A Role for De Novo Fatty Acid Synthesis in Reproduction and Adult Survival 
In addition to probing known genetic pathways, we also used this technology to 
understand the role of lipogenesis at various life stages in the animal. In these studies, we 
found a key role for altered fat metabolism at the onset of reproduction. We believe that 
these studies have major implications for how the field thinks about fat metabolism. There 
are many instances where the function of a gene or pathway is assumed to be constant 
throughout its growth and development; however, we believe that this represents a need to 
consider developmental stage in comparative studies. 
Additionally, when the key fatty acid synthesis gene, FASN-1, is inhibited, we found a 
reduction of adult lifespan. Besides the generation of fatty acids when fat is not present in 
the diet, an essential role for fatty acid synthesis in the adult animal has not been described 
in any species. These experiments led us to a model that suggests a key role for altered fat 
metabolism in allowing animals to survive reproduction. We believe that the role of fatty 
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acid synthesis in lifespan after reproduction should be considered in the development of 
therapeutics that alter fatty acid metabolism. 
The Impact of Oxidative Phosphorylation on De Novo Fat Synthesis 
We have also employed the mixed labeling strategy to define how perturbations in 
metabolic pathways can influence overall fat metabolism. In cancer cells, there is a 
lipogenic shift that results in the vast majority of fatty acids coming from de novo fatty acid 
synthesis. The redox balance model suggests that the high levels of fatty acid synthesis are 
a necessary compensation mechanism to generate adequate levels of NAD+ to run 
glycolysis. Using the nematode, we have found that increased fatty acid synthesis is a 
result of decreased electron chain activity. We have used this model to identify genes that 
are required for this transition and have established roles for the HIF-1 and DAF-16 
transcription factors. There are many open questions about the relative contributions of 
certain metabolic pathways to cancer cell metabolism, and the establishment of C. e/egans 
as a model for studying aerobic glycolysis will allow the relative impacts of pathways like 
NADPH generation to be defined. 
Defining the Impact of Fatty Acid Synthesis 
Using the isotope labeling technology, we have been able to define several genes 
and conditions that impact the levels of de novo fatty acid synthesis; however, the next step 
is to define the importance of fat synthesis in these processes. We believe that increased 
de novo synthesis is an essential component for efficient reproduction and for survival with 
decreased electron chain function; however, to address these questions, inhibition of fatty 
acid synthesis in these states would be essential. Additionally, our studies with fasn-1 RNAi 
have already established a role for fatty acid synthesis in adult lifespan. Next, it will be 
important to define the function of this pathway in adults. 
Further Development of Isotope Technology in C. e/egans 
The feeding of a stable isotope labeled diet has many more potential applications in the 
nematode. Stable isotope labeling can be used to map other features of lipid metabolism 
like fatty acid turnover and food choice as well as monitoring the synthesis, turnover and 
dynamics of almost any other cellular molecule (Appendix /I). Molecules that contain carbon 
or nitrogen, like proteins and DNA, can be studied with the same labeling techniques we 
106 
have described. Preliminary studies have indicated that heavy water, D20, can be 
incorporated into the agar plates that the nematodes live on. Because the nematode gets 
its water from the plate, we have been able to monitor the incorporation of deuterium into 
the lipids of starved nematodes. This and other types stable isotope incorporation studies 
will allow for metabolism to be explored in unique contexts. The study of metabolic flux and 
turnover in the worm with stable isotopes has several advantages including cost 
effectiveness and genetic tractability; however, studies in other systems like mammalian cell 
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Figure 6,1, Summary of Screened Mutants: Over the course of these studies, we 
have investigating the impact of a number of genes, pathways and processes on fatty 
acid synthesis. This graph represents the relative contribution of these studies with 
disruptions leading to increased relative synthesis (green), no change in synthesis 
(black) and decreased relative synthesis (blue). It should be noted that the data here 
was collected using different methods including mutant strains, drug treatment and 
overexpression lines. 
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Appendix I: Novel Regulators of Fatty Acid Synthesis 
Summary 
In order to define new regulators of de novo fatty acid synthesis, we screened a number of 
genes that have been previously implicated in the regulation of fat storage or longevity. 
Through these efforts, we have identified a number of novel regulators of de novo synthesis 
including genes encoding enzymes in peroxisomal ~-oxidation, acyl-CoA metabolism, and 
oxidative phosphorylation. Additionally, this screening approach has identified two novel 
genes which we have named bjgh lipid §Ynthesis (hIs) genes. One of these novel genes, 
hls-1, encodes a Type I Pl3-Kinase which may function in the insulin signaling pathway. 
Here, we describe the progress we have made to further understand these regulators and 
the pathways that they function in. 
Screen of Mutants with Elevated Nile Red Staining 
A genome-wide RNAi screen identified a set of genes that when knocked down resulted in 
changes in fat storage as assayed by Nile Red staining (Ashrafi et aI., 2003). We first 
identified genes that resulted in increased Nile Red staining that had available homozygous 
mutant strains. Then, we quantified the amount of fatty acid synthesis for these strains and 
identified three novel regulators of fatty acid synthesis, maoc-1 (MAO-C-like dehydratase 
domain), hls-1 (high lipid synthesis) and hls-2. 
Peroxisomal f3-oxidation Pathway Regulates Lipogenesis 
The most notable of the screen hits was the maoc-1 strain which encodes an ortholog of 
human hydroxysteroid (17-beta) dehydrogenase 4 (HSD17B4) which is a multifunctional 
enzyme that functions in the peroxisomal ~-oxidation pathway (Moller et aI., 1999). The 
peroxisomal-~ oxidation pathway is responsible for the oxidation of long chain fatty acids 
(C1S-C20), very long chain fatty acids (>C20) and branched fatty acids (Figure A.1A). The 
products of this oxidation are then exported to the mitochondria where they can be fully 
oxidized to produce energy. Once maoc-1 was identified in the screen, we wanted to assay 
if elevated synthesis was inherent to all peroxisomal ~-oxidation mutants. To do this, we 
assayed synthesis in deletion strains for other genes that encode other enzymes in the 
pathway, dhs-28(tm2581) and da f-22 (m 130) (Figure A.1 B). We found an increased 
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synthesis phenotype in all these strains which is the first time a connection between 
peroxisome ~-oxidation and de novo lipogenesis has been identified. 
In C. elegans, the peroxisomal-~ oxidation pathway has recently been implicated in the 
biosynthesis of the dauer pheromone (Butcher et aI., 2009; Joo et aI., 2009). The dauer 
pheromone called daumone is continuously secreted into the environment by the 
nematodes where is used to assess population density, and animals with mutations in 
peroxisome ~-oxidation genes fail to produce the normal pheromones. Because these 
mutants cannot synthesize daumone, they are not capable of inducing the dauer formation 
when unfavorable growth conditions including high population density and low food 
availability are encountered. Dauer formation is known to be regulated by multiple signaling 
pathways that orchestrate changes in fat metabolism, stress resistance and longevity genes, 
so we next wanted to assess whether the increased fatty acid synthesis we see in these 
mutants is due to a failure to regulate dauer signaling pathways. Because the role of the 
insulin pathway in dauer formation is well established, we addressed this question by 
looking at role of insulin signaling in this response by constructing a maoc-1;daf-16 worm 
strain. In these animals, the synthesis increase is intact suggesting that the impact of 
peroxisomal ~-oxidation of fatty acid synthesis is independent of insulin signaling (Figure 
A.1 C). We believe that daumone is acting downstream of the insulin pathway on the 
nuclear hormone receptor, DAF-12, and we are currently investigated that possibility. 
However, we also cannot exclude the alternate model that the impact of peroxisome ~­
oxidation of fatty acid synthesis is independent of daumone synthesis entirely. 
A New Pl3-Kinase Regulates Lipogenesis in Nematodes 
In our screening effort, we found a novel gene, F39B1.1, which we named tJjgh lipid 
§ynthesis (h/s-1) but has subsequently been named piki-1(Qhosphojnositide-3-!5inase). This 
gene has homology to a mammalian Type" Pl3-Kinase (P13KC2a), and we have 
established that HLS-1 has kinase activity in vitro (data not shown). In mammalian systems, 
Type" P13-Kinases have been shown to respond to insulin (Brown et aI., 1999). Therefore, 
we are currently testing whether h/s-1 functions downstream of DAF-2 to regulated 
lipogenesis. Preliminary studies have found that the regulation of fatty acid synthesis by h/s-
1 requires the activity of daf-16 (Figure A.2A). We are currently investigating whether h/s-1 
may specifically regulate de novo fatty acid synthesis downstream of the insulin signaling 
pathway (Figure A.2B). 
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A Novel Worm Specific Regulator of Fatty Acid Synthesis 
From our screen of high fat mutants, we also identified a previously uncharacterized 
gene, M70.1 that we since named bjgh lipid §Ynthesis (hls-2). This gene includes a WSN 
(worm specific N terminal) domain and has no identifiable human homolog; however, the 
protein is predicted to be localized to the membrane. When fatty acid synthesis is measured 
across fatty acid species, we found that the synthesis increase is not uniform and becomes 
more dramatic as the fatty acids become increasingly polyunsaturated (Figure A.3A). By 
constructing a hls-2;daf-16 double mutant and assaying its rates of lipogenesis, we found 
that the increase in fat synthesis is mediated by the DAF-16 transcription factor (Figure 
A.3B). 
Acyl-CoA Synthase 
In a non-biased mutagenesis screen utilizing the lipophilic dye, Nile Red, one of the 
nematode acyl-CoA synthase genes, acs-3, was identified as a regulator of fat storage. In 
order to determine the source of the excess fat staining, we measured fat uptake and fatty 
acid synthesis in acs-3 mutant animals in collaboration with the Ashrafi lab. These studies 
revealed that acs-3 animals have both increased dietary fat uptake as measured by 
BODIPY labeled fatty acid incorporation and increased fatty acid synthesis as quantified by 
mixed 13C isotope labeling (Figure A.4A and (Mullaney et aI., 2010)). 
Because asc-3 animals are sensitive to L Y294002, a broad spectrum 
phosphatidylinositol 3-kinase (PI3-Kinase), we performed a screen to identify suppressors of 
the L Y294002-induced developmental arrest of the asc-3 mutants. This screen identified 
three suppressors: a long-chain acyl-CoA dehydrogenase (acdh-11), a medium-chain acyl-
CoA dehydrogenase (acdh-1 0) and a fatty acid elongase (eI0-6). All three suppressors can 
rescue the fatty acid uptake and fat storage phenotypes; however, only e10-6 can suppress 
the increased fatty acid synthesis phenotype (Figure A.4). 
A Role for TORC2 in Regulating Lipogenesis 
In a screen for mutants of altered lipid storage, the Ashrafi lab isolated two alleles of the 
C. elegans rictor homolog which they named Ipo-6 (lipophilic dye abnormal). The Ipo-6 
gene encodes Rictor which functions in the TOR (target of rapamycin) pathway as the 
binding partner of the TORC2 complex (Jones et aI., 2009). We tested the role of Ipo-6 in 
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regulating lipogenesis and found that there is a significant enrichment in synthesized fatty 
acids. We have found that the increase in synthesis is not seen in palmitate, but in the other 
fatty acid species of the worm (Figure AS) 
Reduced Fatty Acid Synthesis in bbs-1 Animals 
Mutations in the human bbs-1 gene have been associated with Bardet-Biedl syndrome. 
Because Bardet-Biedl syndrome is characterized by an increased propensity for obesity, 
there has been interest in defining how the bbs-1 gene may impact lipid metabolism 
pathway. When we assayed these animals for synthesis, we found a decreased abundance 
in synthesized fatty acids (Figure AS). Because these animals are high in fat, this result 
suggests an increase in dietary fatty acid absorption consistent with gene expression 
analysis (Mak et aI., 2006). 
Overexpression of nhr-69 Eliminates Lipogenic Increase Seen at Adulthood 
We measured de novo fatty acid synthesis in a worm strain that overexpresses the 
nhr-69 (generated and provided by D Gems) and found that these animals fail to upregulate 
synthesis between L4 and adulthood (Figure A6A). These animals allowed us to test the 
importance of this increase by assaying lifespan and brood production in animals that fail to 
upregulate synthesis. We found that these animals have severely compromised brood 
production and a shortened lifespan, supporting the model we presented in Chapter IV 
(Figure A6B). Although further study is needed, this suggests that there is genetic 
regulation of the increase in adults. 
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Appendix II: Other Stable Isotope Labeling Strategies in C. e/egans 
Summary 
The implementation of stable isotope technology has many potential utilizations in the 
nematode including RNAi screening, fat turnover studies and food discrimination studies. 
Additionally, other elements can be labeled depending on the types of hypotheses tested. 
For example, we have used heavy H20 to look at label incorporation in starved animals 
where we cannot introduce label via the diet. Here, we also describe our efforts to expand 
the utility of isotope labeling approaches in nematodes by adapting the isotope strategies to 
be compatible with RNAi feeding technologies. 
Compatibility with RNAi Feeding Platforms 
Our current analysis has been limited to assaying the regulatory role of genes that 
have mutant strains available; however, there are many genes of interest that do not yet 
have developed strains. We therefore sought to expand this technology to be compatible 
with RNAi feeding. The primary hurdle to RNAi feeding compatibility is that mixed isotope 
feeding plates are prepared with agarose media to eliminate excess unlabeled carbon 
incorporation by growing bacteria. Because RNAi induction by IPTG requires actively 
growing bacteria, we have approached this problem in two distinct ways to with some 
success. First, we have experimented with induction of RNAi production in liquid cultures 
before plating on agarose plates. This method has shown success with several RNAi 
strains including fat-7 RNAi as shown; however, this strategy does not sustain long-tern 
RNAi inhibition and may not be suitable for RNAi of all genes. 
The second strategy that we have employed is to isotope label worms on NGM growth 
plates. We have done preliminary experiments with the daf-2 (e1370) strain to establish that 
the isotope patterns are intact despite the presence of unlabeled 12C in the plates. This 
strategy will allow us to ensure induction of RNA interference; however, it will require further 
processing of the data. Additionally, both of these methods will ultimately require the growth 
of small individual bacterial cultures. 
Lipid Turnover Studies 
In order to measure fatty acid turnover rates, a population of fully 13C bacteria were fed 
to the nematodes for a defined period. In these studies, we have found that extremely high 
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levels of fatty acid turnover especially in that phospholipids of the animal (Figure A6). We 
next wanted to determine if turnover of fatty acids are constant over aging, and we found 
that fatty acid turnover rates decrease as the animals age (Figure A7). We are currently 
investigating the role of membrane turnover in the aging process. 
Food Discrimination Assays 
Previous studies have found that the nematodes preferentially move to bacterial lawns of 
"high quality" food sources (Shtonda et aI., 2006). However, it is not known whether the 
nematodes respond only to populations of bacteria or whether the nematode can distinguish 
between individual bacterium. To test these possibilities, we labeled a population of P. 
aeruginosa with 99% 13C and found that we could determine the preference for the bacteria 
by quantifying the amount of 13C in the lipids of the worms. We extended these studies to 
find that when we mixed the 13C-labeled P. aeruginosa with 12C-labed E. coli the nematodes 
still favored the E. coli population (Figure AS). 
2H20 Studies in Nematodes 
One of the limitations of the 13C-labeled food incorporation is that the animals must be 
eating in order to be exposed to the stable isotope. Because we are also interested in 
measuring metabolic pathways in starved animals, we made use of the fact that nematodes 
get water directly from their feeding plates. We then poured growth plates with heavy water, 
2H20 and put worms on unseeded plates. In these preliminary studies, we saw a small but 
significant accumulation of deuterium in the animals suggesting this labeling approach will 





































Figure A.1: Mutations in the peroxisomal f3-oxidation pathway have increased 
lipogenesis. (A) Diagram of the peroxisome f3-oxidation pathway. (8) Mutations in 
each component tested has elevated fatty acid synthesis in total lipid. (C) Epistatic 
studies have found that the increased synthesis observed in the maoc-1 animals 






















Figure A.2: hls-1 animals have elevated fatty acid synthesis dependent on 
daf-16. (A) Fatty acid synthesis is increased in the hls-1 mutants as shown with 
palmitate synthesis. In hls-1;daf-16 double mutants, synthesis rates are rescued 
suggesting that hls-1 interacts with the insulin signaling pathway. (8) We are 






































Figure A.3: HLS-2 regulates lipogenesis. (A) hls-2 animals have increased 
synthesis especially in longer fatty acids. Data are shown as percentage of 
synthesized fatty acid ± SEM. (8) Preliminary experiments have established 
that the increased synthesis observed in hls-2 animals depends on DAF-16 as 
hls-2;daf-16 animals (purple) have reduced synthesis. Data from hls-2;daf-16 
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Figure AA. ACS-3 Increases Fat Synthesis in ELO-6 Dependent Manner: (A) The 
acs-3 animals show increase fatty acid synthesis in all fatty acid species measured 
(blue). The acs-3;eI0-6 (green) animals are partially rescued with synthesis levels 
slightly above wildtype (black). e10-6 anmsils have WT synthesis (grey). (8) ACS-3 
Increases Fat Synthesis independent of ACDH-10 and ACDH-11. The levels offatty 
acid synthesis are elevated in acs-3 (blue), acs-3;acdh-10 (orange), and acs-3;acdh-11 
(red) animals. The levels of synthesis are normal in acdh-10 (light orange) and 
acdh-11 (light red) single mutants. Data shown is from a minimum of 5 experiments 
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Figure A.S. Synthesis Quantification in bbs-1 and Ipo-6 Mutants: We quantified 
de novo fatty acid synthesis in other animals that have been implicated in fat storage 
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Figure A.6. Overexpression of nhr-69 Eliminates Lipogenic Increase Seen in 
Adults: (A) We quantified de novo fatty acid synthesis in over::nhr-69 animals 
(purple). These animals also had a reduced brood (8) and a short lifespan (C). 
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Figure A.7. Use of Stable Isotopes to Monitor Fatty Acid Turnover: (A) In order to 
quantify fatty acid turnover, we grew worms on unlabeled 12C bacteria until early 
adulthood. We then transferred those animals to 99% 13C bacteria for a 24 hour 
period. (8) In young adults, we found very high levels of fatty acid turnover in both 




L... 04 Q) 
> 50 0 06 c 
L... 40 ::J 08 I-
"'C 30 - 010 '() 
« 
1J - 012 >. 20 -~ -
- 014 co 
LL 10 -
~ 11- ~ .... 0 0 '--, I 
C16:0 C18:1n9 C18:2n6 
Figure A.S. Fatty Acid Turnover Decreases Over Aging: Although rates of fatty acid 
turnover start off quite high, there is an aging dependent decrease in fat turnover. 
Data is shown from one data set of purified phospholipids but the trend has been 
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Figure A.9. Isotope Based Food Discrimination Studies: (A) In order to determine 
if the nematodes had a preference for a specific food source, we labeled one food 
source with 99% 13C and monitored the incorporation of label into the worm's fats . 
This allowed us to determine if the animals could only distinguish E. coli (circles) from 
Pseudomonas aeriginosa (rectangles) in a "split" plating where populations of bacteria 
could be sensed or if the distinction could still be made based on an individual 
bacterium in the "mix" plating. (8) We found that the worms preferred the E. coli 
regardless of the plating format. The type of bacteria labeled with 13C was also 
switched with the same results. 
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